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Selenoprotein H (SELENOH) is a nucleolar oxidoreductase with DNA binding
properties whose function is not well understood. To determine the functional and
physiological roles of SELENOH, a knockout of SELENOH was generated in cell lines
using CRISPR/Cas9-mediated genomic deletion and in mice by targeted disruption.
Based on the sequenced genome, the results of deduced protein sequences indicated
various forms of mutants in the CRISPR/Cas9-mediated knockout, including a frameshift by aberrant splicing and truncated SELENOH by early termination of the translation
process. Loss of SELENOH in HeLa cells induced slow cell proliferation, the formation
of giant multinucleated cells, accumulation of unrepaired DNA damage and oxidative
stress, and cellular senescence. SELENOH cells were enlarged and possessed a single
large nucleolus. Atomic force microscope showed increased stiffness in the nucleoli of
SELENOH knockout cells, which suggests that SELENOH maintains the flexible
structure of the nucleolus. Furthermore, the knockout of SELENOH led to a large-scale
reorganization of the nucleolar architecture with the movement of nucleolar protein into
nucleolar cap regions in response to oxidative stress. The nucleolar reorganization is
dependent on ATM signaling. Altogether, results suggest that SELENOH appears to be a

sensor of oxidative stress that plays critical roles in redox regulation and genome
maintenance within the nucleolus.
To determine the physiological role of SELENOH in vivo, Selenoh knockout mice
were generated by targeted deletion through homologous recombination. Selenoh+/− mice
were fertile and phenotypically indistinguishable from wild-type littermates. Results from
matings of Selenoh+/− mice showed a significantly reduced fraction of Selenoh−/−
offspring on the basis of Mendelian segregation. Since some Selenoh−/− were born, it is
likely that Selenoh is a partially essential gene in mice. Live-born Selenoh−/− mice were
viable and born without apparent phenotypes. Selenoh−/− mice at 2-month of age showed
increased GPX activity in the lung but not in the brain and liver. Furthermore, loss of
Selenoh resulted in the aggravated formation of aberrant crypt foci in the colon of
Selenoh+/− mice that were injected with azoxymethane. Altogether, SELENOH has
critical roles in embryogenesis and colorectal carcinogenesis.
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INTRODUCTION
1.1 Selenium
1.1.1 Nutritional essentiality
Selenium (Se) was identified as an element in 1817 by the Swedish chemist Jöns
Jacob Berzelius (Berzelius 1818). Since the discovery of Se, this element was best known
as a toxicant until 1957 when liver necrosis was found in rats that were fed a Se-deficient
diet (Patterson et al. 1957; Schwarz et al. 1957; Schwarz & Foltz 1957). Other
syndromes of dietary Se deficiency were subsequently found in other animal species,
including exudative diathesis with pendulous appearance of the neck in chicks (Patterson
et al. 1957; Schwarz et al. 1957), muscular dystrophy or white muscle disease in lambs
(Hogue 1958; Muth et al. 1958), and mulberry heart disease in pigs (Van Vleet et al.
1970). Human Se deficiency syndromes include Keshan disease, which is characterized
by cardiomyopathy, Kashin-Beck disease, which is characterized byosteochondropathy,
and myxoedematous cretinism, which is characterized as a waxy or coarsened skin
appearance (Yang et al. 1988; Vanderpas et al. 1990; Moreno-Reyes et al. 1998). These
deficiency syndromes animal species and human led to the establishment of Se as a
nutrient.
Nutrient regulation of gene expression is common, but Se is the only nutrient that
is directly involved in the translation process. Se exerts its physiological function mainly
1

through selenoproteins, which are widespread in all three domains of life. However, the
number of selenoprotein genes varies by species, ranging from 0 in fungi and some
animal species such as beetles and silkworms, 1 in C. elegans, and as many as 59 in the
pelagophyte Aureococcus anophagefferens (Labunskyy et al. 2014). In rodents and
humans, the numbers are 24 and 25, respectively. Selenoprotein mRNAs contain the inframe UGA codon, a stop codon elsewhere, which decodes for selenocysteine at the
active site of all selenoproteins. The Se transporter selenoprotein P (SELENOP) contains
ten selenocysteine residues, but all other selenoproteins in mammals contain only one
selenocysteine. It has been widely accepted that selenocysteine is the “21st” amino acid,
whose three and one letter abbreviations are assigned as Sec and U, respectively.
Selenoprotein mRNAs are translated when selenocysteine-tRNAs carrying the anti-codon
in complimentary to UGA and the selenocysteine moiety is added to a nascent
polypeptide (Labunskyy et al. 2014).
Before the complete sequencing of the human genome in 2003 and the
characterization of the selenoproteome by the Gladushev Lab (Kryukov et al. 2003), it
was known that dietary Se fluctuations affect the regulation of selenoprotein expression
at mRNA and protein levels. This was determined by evaluating individual
selenoproteins such as glutathione peroxidase-1 (GPX1), thioredoxin reductase-1
(TXNRD1), and iodothyronine deiodinase-1 (DIO1), and SELENOP (Meinhold et al.
1993; Cheng et al. 1998a; Holmgren 2000). When dietary Se supply is low, Se delivery
to selenoproteins through selenocysteine-tRNA is hampered, which stops the and thus
translation of selenoprotein mRNAs at the UGA codon. These results in the degradation
of selenoprotein mRNAs by nonsense-mediated mRNA decay and the incomplete
2

translation of selenoprotein by the ubiquitin ligase-mediated pathway (Seyedali & Berry
2014; Lin et al. 2015).
The “hierarchy concept” of Se distribution to tissues and selenoproteins was first
proposed and developed by Dietrich Behne based on studies of 75Se distribution in tissues
and proteins of Se-deficient rats (Behne et al. 1988). These hierarchies of Se indicate that
Se is prioritized to essential selenoproteins and tissues at the expense of other tissues and
selenoproteins that do not have an immediate need to allocate Se for survival. In rodents,
dietary Se deficiency prioritizes depletion of this nutrient in the liver and kidney but
retention in the brain and testis. More recent studies demonstrate Se retention in the brain
and testis is made possible through SELENOP and the tissue-specific expression of a
SELENOP receptor apolipoprotein E receptor-2 in these two organs (Burk et al. 2007;
Olson et al. 2007; Olson et al. 2008; Hill et al. 2012). SELENOP delivers Se from liver
to brain and testis through binding to the apolipoprotein E receptor-2 and the subsequent
endocytosis. Once inside the cells of these organs, selenocysteine residues on SELENOP
are excised by selenocysteine lyase to release selenide for tissue usage. SELENOP
mainly transfers Se from the liver to the brain and testis through the nine selenocysteine
residues in its C-terminal domain (Schomburg et al. 2003; Hill et al. 2007). While the
expression of apolipoprotein E receptor-2 is extremely low in tissues that are low in Se
hierarchy such as the kidney and liver, it is highly expressed in the testis and brain. This
observation is consistent with the pivotal roles of Se in male reproduction and optimal
brain functions. Strikingly, Se concentrations are increased by 3.3-fold and 80%,
respectively, in the brain and testis but decreased by 80% in the liver of mice that were
fed a Se-deficient diet for 18 weeks (Burk & Hill 2009). Among those tissues that are
3

ranked high in tissue Se hierarchy, competition for the available Se is observed since
castration is known to increase the Se concentration in the brain of Scly−/−Sepp1−/− mice
that have compromised Se transport and unitization (Pitts et al. 2015). Similarly, when
body Se status is low, the depletion of GPX1, SELENOH, and SELENOW is faster than
other selenoproteins such that these three selenoproteins are ranked at the bottom of
selenoprotein hierarchy (Behne et al. 1988; Sunde & Raines 2011). Over the last 20
years, the mechanism by which selenoprotein hierarchy is regulated is becoming clear. In
Se deficiency, selenoprotein hierarchy is partially attributed to nonsense-mediated decay
or SECIS-binding mediators such as the stimulatory nucleolin and the inhibitory
eukaryotic initiation factor 4a3 at the mRNA level, CRL2 ubiquitin ligase-mediated
degradation of mis-incorporated or mis-folded selenoproteins, and choices of isoforms of
selenocysteinyl-tRNA (Moustafa et al. 2001; Budiman et al. 2009; Miniard et al. 2010;
Seyedali & Berry 2014; Lin et al. 2015). Such Se homeostasis and selenoprotein
regulation are consistent with the observation of selenoprotein hierarchy in testis, as
requirements for Gpx1 mRNA levels are high but Selenop mRNA levels are low in this
organ with priority to the acquisition of Se (Sunde & Raines, 2011).
In addition to selenoproteins, Se can be found in two other classes of Secontaining proteins that uphold Se non-specifically or independent of the UGA codon.
First, as a result of sharing a chemical similarity in the chalcogen family of elements, Se
may no-specific replace sulfur in methionine and cysteine residues of any protein.
Second, as a result of structural configuration that is compatible with Se binding, there
are two non-selenoproteins, Se-binding protein-1 and 14-kDa fatty acid binding protein,
which specifically bind Se, despite the lack of selenocysteine. Besides, Se at
4

supranutritional levels may form Se metabolites that induce oxidative stress to modulate
biological processes such as activation of earlier barriers of tumorigenesis at relatively
lower doses in non-cancerous cells through senescence induction (Wu et al. 2010) or high
doses in cancer cells through apoptosis (Jackson & Combs 2008). Thus, body Se status
can influence physiological and pathophysiological conditions at nutritionally adequate,
supranutritional, and toxic levels, primarily through selenoproteins and to a less extent
through Se metabolites.
The essential nature of selenoproteins is evidenced by a model that deletes all 24
selenoproteins in mice. Noticeably, although it is technically feasible to use an amino
acid-basal diet to dramatically reduce Se content in a purified diet, the residual Se that
remains in the diet is sufficient to enable the expression of certain “high hierarchy”
selenoproteins such as glutathione peroxidase-4 (Lei et al. 1995). Thus, it remains the
only approach to assess the essentiality of total selenoproteins by the knockout of Trsp,
the gene that encodes selenocysteine tRNA, in mice (Bosl et al. 1997). Since Trsp−/−mice
are embryonic lethal, it is clear that at least some selenoproteins are essential to
development and survival. So far, it is known that knockouts of glutathione peroxidase-4,
thioredoxin reductase-1 and thioredoxin reductase-2 render mice embryonic lethal
(Zhang et al. 2016) whereas some selenoproteins are not essential for life, including
glutathione peroxidase 1-3 and SELENOP (Lei et al. 2016). However, these “nonessential” selenoproteins play important roles during stressed or diseased conditions.
These includes the critical role of glutathione peroxidase-1 in response to acute oxidative
stress (Cheng et al. 1998b), glutathione peroxidase-2 in tumorigenesis (Florian et al.
2010), and SELENOP in Se delivery (Florian et al. 2010).
5

The 25 selenoproteins in humans are grouped into families of glutathione
peroxidase, thioredoxin reductase, iodothyronine deiodinase, Se storage and transport
regulation, and those involving protein quality control. Selenoproteins are differentially
expressed in various tissues and sub-cellular compartments under various physiological
and pathophysiological conditions (Squires & Berry 2008; Zhang et al. 2010; Labunskyy
et al. 2014). Based on the triage theory of aging proposed by Bruce Ames, 11
selenoproteins are sensitive to body Se fluctuations and are predicted to play important
roles during the aging process (McCann & Ames 2011). Although Trsp−/−mice are
embryonic lethal, conditional knockout of Trsp in mice is viable, and they show such
aging phenotypes such as alopecia in epidermal cells of Trsp−/− mice (Sengupta et al.
2010) and bone abnormality in osteo-chondroprogenitor cells of Trsp−/− mice (Downey et
al. 2009). Our Lab has a special interest in genome maintenance and nuclear
selenoproteins. Indeed, selenoprotein H (SELENOH) is the only selenoprotein that is
predicted to be localized only in the nucleolus (Zhang et al. 2016), which has been
experimentally verified when SELENOH is expressed together with a Green fluorescent
protein (GFP) tag (Novoselov et al. 2007). It is well established that genome instability is
one of the major factors that regulate aging, cancer, and other chronic diseases (Campisi
2005). Thus, it is of great interest to understand interactions between selenoproteins and
Se metabolites in genome maintenance, aging, and age-related degeneration.

1.1.2 Selenium metabolism
The chemical forms of Se influence its bioavailability, retention, and metabolism
(Van Dael et al. 2002; Wastney et al. 2011). Selenomethionine is the major dietary
6

source of Se from foods and foodstuffs in humans and animals. Although the exact
mechanisms are unclear, selenomethionine is released in the enzymatic digestion of
proteins and absorbed in the small intestine via simple or carrier-mediated diffusion
and/(or) active transporters such as those for methionine transport. Similarly, it has been
reported that selenomethionine competes with methionine for intracellular transport in
Caco-2 colorectal cells (Thiry et al. 2013). Analyses of plasma Se concentrations in
subjects over a wide range of Se status indicates that bioavailability is greater when it is
originated from selenomethionine than inorganic forms (Xia et al. 2005; Burk et al.
2006). In the body, the majority of Se at nutritional levels of intake is retained in the body
through co-translational incorporation by selenocysteine-tRNAs into selenoproteins and
non-specific integration in sulfur-containing amino acids, this is because these two
chalcagon elements share chemical similarities. At levels above the nutritional
requirement, a significant amount of absorbed Se can be excreted through feces and urine
with urine loss as the major excretory route (Pedrosa et al. 2012). While methylated Se
compounds are the major form of urinary Se (Zeng & Combs 2008), they vary among
species. The trimethylselenonium ion ([CH3]3Se+) and the selenosugar (1β-methylselenoN-acetyl-D-galactosamine) are prominent forms of urinary Se in rats and humans
(Kobayashi et al. 2002). To understand Se metabolism in an integrated manner, the fact
that multiple forms of Se are usually consumed simultaneously has been taken into
consideration in an attempt to develop mathematical models to effectively describe the
absorption, distribution, and retention of total Se(Patterson et al. 1989; Wastney et al.
2011). These predictions take advantage of the available stable isotopes of Se and the oral
administration of both organic and inorganic Se such as 74Se as selenomethionine and
7
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Se as sodium selenite, followed by the assessment of the consumed amount and the

amounts in the blood, urinary and fecal samples through analyses of these Se tracers.
Glutathione peroxidase-3 (GPX3) and SELENOP are the two extracellular
selenoproteins. SELENOP accounts for 76% and GPX3 21% accounts for the total Se in
plasma (Olson et al. 2010). The minimum dietary Se that is needed to saturate liver Se
concentration and Selenop mRNA are 0.11 µg and 0.01 µg Se/g, respectively (Sunde et
al. 2016). These results indicate that Se in the liver is prioritized to SELENOP, which
corroborates its essential role in supplying Se to other tissues through circulation (Hill et
al. 2012). GPX3 does not seem to play an important role in Se delivery based on the
results from Selenop−/−Gpx3−/− mice that were fed a moderately high Se diet (Olson et al.
2010). In Se deficiency, Se retention is prioritized via tissue-specific SELENOP
receptors. These include delivery to the kidney through Megalin and to a greater extent,
to the brain and testis through the apolipoprotein E receptor-2 (Burk et al. 2007; Olson et
al. 2008; Hill et al. 2012). We have recently shown that there are sex differences in
SELENOP expression, as there is 1.4-fold greater plasma SELENOP decline by Se
deficiency in females than males. Such sex differences might help to explain the greater
number of downregulated selenoprotein mRNAs by dietary Se deficiency in the kidney in
females when compared to males (16 vs. 4) but not in the heart (5 vs. 4) (Cao et al.
2017). The heart expresses very little Megalin or apolipoprotein E receptor-2 for Se
import and is allocated with only 0.7% of the total Se in Se(+) rats (Behne & Wolters
1983; Burk & Hill 2015). Liver Selenop mRNA levels are significantly decreased in
females on a Se-deficient diet containing 0.03 µg Se/g, a moderately deficient level
known to saturate Selenop expression in growing mice (Sunde et al. 2016). Furthermore,
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there is a 50% decrease in the dietary Se requirement to saturate the liver Se in 1-yr-old
rats when compared to growing female rats (Sunde & Thompson 2009). Altogether, it is
clear that Se delivery differs due to age and sex. It is also plausible to speculate that
SELENOP hierarchy descends as female mice age.
1.2 Selenoproteins
1.2.1 Incorporation of selenium into selenoproteins
In the early 1970s, Se-containing proteins were located in mammals and bacteria.
In 1972, it was found that a tissue fraction isolated from rats injected with 75Se contained
both this stable isotope and GPX activity, suggesting that Se is a prosthetic group of this
enzyme (Flohe et al. 1973; Rotruck et al. 1973). In addition, two Se-containing proteins,
“protein A” in the glycine reductase system and formate dehydrogenase, were identified
in Clostridium Thermoaceticum (Andreesen & Ljungdahl 1973; Turner & Stadtman
1973). From the studies in C. Thermoaceticum, selenocysteine was later identified in
protein A (Cone et al. 1976). Selenocysteine incorporation into proteins was cotranslational through an otherwise stop codon, UGA (Chambers et al. 1986). This
prompted question of how translation of selenoprotein mRNAs avoided the use of the inframe UGA as a stop codon. This is further elucidated in prokaryotes. Selenocysteine
insertion into bacterial selenoproteins and its biosynthesis are mediated by gene the
products of selA, selB, selC, and selD that encode selenocysteine synthase, a specialized
translation factor, selenocysteine tRNA, and selenophosphate synthetase, respectively
(Böck 2001). It was later determined that, despite the increased complexity and
incomplete understanding, mammalian biosynthesis of selenocysteine largely follows a
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similar pattern to that of bacteria (Labunskyy et al. 2014). Three unique and essential cisand trans-acting factors exist for translation of in-frame UGA in selenoprotein mRNAs as
selenocysteine. They are 1) the selenocysteine tRNA (encoded by TRSP with additional
modifications, elaborated below) that decodes UGA (Lee et al. 1989; Berry et al. 1991a);
2) the selenocysteine insertion sequence (SECIS) in the 3’-untranslated region of all
selenoprotein mRNAs (Lee et al. 1989; Berry et al. 1991a); 3) a SECIS-binding protein 2
(SBP2, encoded by SECISBP2) that stabilizes SECIS and brings about selenocysteine
tRNA. It is a complicated process to synthesize mature selenocysteine tRNA from the
gene product of TRSP. This requires the sequential enzymatic reactions of seryl-tRNA
synthetase, phosphoseryl-tRNA[Ser]Sec kinase, and selenocysteine synthase (encoded by
SEPSECS) on the TRSP gene product. Interestingly, TRSP encodes a precursor of both
selenocysteine and cysteine tRNAs. Although these two tRNAs are catalyzed by
selenocysteine synthase, the synthesis of selenocysteine or cysteine tRNA depends on
whether monoselenophosphate (H2SePO3-) or thiophosphate (H2SPO3−) is incorporated
into the serine moiety on tRNA[Ser]Sec. As such, misincorporation of cysteine at the
selenocysteine residue may occur, and this is stimulated by Se deficiency (Labunskyy et
al. 2014). Because Trsp−/− mice are embryonically lethal (Bosl et al. 1997), this suggests
that at least some selenoproteins are also embryonic lethal. Interestingly, a couple of
human mutations in genes that were necessary for selenoprotein synthesis are identified
in patients. These include TRSP (Schoenmakers et al. 2016), SECISBP2 (Schoenmakers
et al. 2010), and SEPSECS (Agamy et al. 2010; Anttonen et al. 2015) in humans.
Defective Se metabolism and phenotypes of these mutations are summarized in Table
1.1. Similar to deficiency in selenocysteine tRNA, mutations in these genes essential for
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translation of selenoprotein mRNA impact all selenoproteins. This is exemplified by the
observations significant decrease in plasma selenium concentrations and certain
selenoprotein expression in tissues of patients with these mutations.
1.2.2 Selenoprotein functions
There are 24 and 25 selenoproteins identified in rodents and humans, respectively,
by a search for SECIS appearance in whole genomes (Kryukov et al. 2003).
Selenocysteine is located in active sites to participate in redox reactions in all known
selenoenzymes. Considering their structures and functions, selenoproteins are categorized
into glutathione peroxidases, thioredoxin reductases, and iodothyronine deiodinases, the
thioredoxin-like, endoplasmic reticulum proteins (Sep15 and selenoprotein M), and other
proteins with functions related to selenium transport and storage. Overexpression or
knockout of a couple of selenoprotein genes in mice has enabled research on their
physiological function of the selenoproteins.
1.2.2.1 Glutathione peroxidases
While the presence of Se in GPX and its importance for the peroxidase activity
were confirmed 1972 (Flohe et al. 1973; Rotruck et al. 1973), the enzymatic reaction of
GPX was discovered in erythrocytes in 1957 (Mills 1957). Because the GPX1 enzyme
that isolated from bovine erythrocyte exhibits “ping-pong” kinetics without saturation
with glutathione (the substrate for GPX), it has an infinite extrapolated Vmax and no true
KM (Flohé et al. 1972; Günzler et al. 1972). While GPX4 is a monomer, GPX1-3 and
GPX6 are homotetramers. Mammalian GPX5 or rodent GPX6 is not a selenoprotein. The
peroxide substrate preference for GPX1-3 and GPX4 is H2O2 and organic
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hydroperoxides, respectively (Brigelius-Flohe & Maiorino 2013). It is interesting that
only GPX4 can catalyze the reduction of phospholipid hydroperoxides. Gene expression
and protein production of the GPX family are tissue- and organelle-specific (BrigeliusFlohe & Maiorino 2013). GPX1 and GPX2 resides mainly in cytosol. While GPX1 is
known to be expressed in all types of cells in all tissues, GPX2 is found almost
exclusively in intestines but to a minor extent in the mammary gland and liver (Chu et al.
1993). Although GPX1 expression is ubiquitous, the highest abundance is found in the
liver, kidney, erythrocyte, and placenta. Previously and commonly known as plasma
GPX, extracellular GPX3 is mainly expressed in and secreted from the kidney and
epididymis (Burk et al. 2011). Different from GPX1-3, Phospholipid hydroperoxide GPX
(GPX4) is a monomer that is expressed highly in the testis, and is found to have three
isoforms in cytosol, mitochondria and the nucleus (Pushpa-Rekha et al. 1995; Maiorino et
al. 2003; Brigelius-Flohe & Maiorino 2013). The cellular localization of GPX6 is
unknown, although human GPX6 is highly expressed in the embryos and the olfactory
epithelium (Dear et al. 1991; Kryukov et al. 2003).
Through the use of Gpx1−/− mice 20 years ago, it was concluded that GPX1
accounts for 60% of total liver Se (Cheng et al. 1998a; Cheng et al. 1999; Fu et al. 1999).
Furthermore, studies that employed Gpx1 knockout mice enabled the discovery of the
first known physiological function of this selenoprotein that protects against acute
oxidative stress that is induced by paraquat and diquat through the redox protection of
lipids and proteins in mice (Cheng et al. 1998b; Cheng et al. 1999; Fu et al. 1999). While
Gpx1−/− mice develop normally, using this line of mice later resulted in the identification
of functional roles of GPX1 in cardiovascular disease, neurodegeneration, and
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autoimmune disorders under stressed or diseased conditions (Lei et al. 2007).
Surprisingly, mice develop a type-2 diabetes-like phenotype when GPX1 is
overexpressed (McClung et al. 2004). Although such an extreme scenario of GPX1
overexpression is unlikely to spontaneously occur in nature, it is speculated that this
paradoxical role of GPX1 is ascribed to over-quenching oxygen free radicals and overdepletion of intracellular H2O2 that hampers insulin signaling. Consistent with this
observation, while insulin resistance is produced by the consumption of a high-fat diet,
such a pathophysiological response is attenuated in Gpx1−/− mice (Loh et al. 2009). On
the other hand, under a more physiological setting, it is known that β-cell specific
overexpression of GPX1 in the leptin receptor was defective db/db in obese mice, but
prevented diabetes and rescues the intrinsic β-cell dysfunction at 20 weeks of age
(Harmon et al. 2009; Guo et al. 2013). Despite these seeming inconsistencies, it is
prudent to conclude that GPX1 differentially regulates glucose homeostasis in response
to distinctive physiological or pathophysiological circumstances.
Although the GPX1 expression is up-regulated in the colon and ileum of Gpx2−/−
mice (Florian et al. 2010), there is no phenotype in Gpx2−/− mice under unstressed
conditions. This is similar to Gpx1−/− mice. In the double knockout model,
Gpx1−/−Gpx2−/− mice show increased lipid peroxidation and develop intestinal tumors
(Esworthy et al. 2001). Considering the same substrate preference, results from these
studies suggest that GPX1 and GPX2 interact to protect against oxidative stress in the
intestines. Consistent with the antioxidative role of GPX1 and GPX2, the cerebral
infarction symptom in Gpx3−/− mice can be relieved by antioxidant treatments (Jin et al.
2011). While the knockout of Gpx1, Gpx2, or Gpx3 in mice do not yield the apparent
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phenotype, GPX4 is an essential selenoprotein as Gpx4−/− mice are embryonically lethal
(Yant et al. 2003). To circumvent this limitation so that the physiological functions of
GPX4 can be studied, various lines of conditional or inducible knockouts of GPX4 have
been generated in mice. Results demonstrated GPX4 protect against the defective
development of photoreceptor cells (Ueta et al. 2012b), male infertility (Imai et al. 2009;
Schneider et al. 2009), and symptoms of neurodegeneration (Seiler et al. 2008).
1.2.2.2 Thioredoxin reductases
There are three thioredoxin (TXN) reductases (TXNRD) in mammals including
cytosolic TXNRD1 (Tamura & Stadtman 1996), mitochondrial TXNRD2 (MirandaVizuete et al. 1999), and the spermatid-specific TXNRD3 (also known as thioredoxin
glutathione reductase) (Su et al. 2005). These three selenoproteins recycle oxidized TXN
at the expense of NADPH and belong to a family of pyridine nucleotide-disulfide
oxidoreductases. TXNRD1 and TXNRD2 are essential proteins because Txnrd1−/− and
Txnrd2−/− mice display embryonic lethality (Conrad et al. 2004; Jakupoglu et al. 2005;
Bondareva et al. 2007). To understand their physiological functions, many conditional
knockouts of Txnrd1 and Txnrd2 have been generated in mice for functional studies of
these two selenoproteins in relation to cancer and neurodegeneration (Jakupoglu et al.
2005; Soerensen et al. 2008; Carlson et al. 2012).
1.2.2.3 Iodothyronine deiodinases
Iodothyronine deiodinases (DIOs) catalyze the transformations between thyroxine
(T4), 3,5,3’-triiodothyronine (T3) and reverse triiodothyronine (rT3) (Arthur et al. 1990;
Berry et al. 1991b). DIO1 or DIO2 remove one iodine from the less active T4 to produce
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the more active T3, followed by secretion from the thyroid gland into circulation.
However, Dio1−/− or Dio2−/− mice do not display abnormal serum T3 levels (Galton et al.
2009), suggesting a redundant role as a deiodinase or a compensatory increase in T4
levels. Indeed, T4 levels in the serum of Dio2−/− mice are increased (St Germain et al.
2009). In addition to the enzymatic role in thyroid hormone maturation, other
physiological functions of DIOs have been shown. First, Dio2−/− mice display hearing
loss, impaired thermogenesis and cognition (St Germain et al. 2009), and increased
susceptibility to ventilator-induced lung injury (Barca-Mayo et al. 2011). Second, Dio3−/−
mice show defective cerebellar development and restrictive cardiomyopathy (Ueta et al.
2012a; Peeters et al. 2013). Third, both DIO2 and DIO3 are involved in glucose
metabolism since Dio2−/− or Dio3−/− mice exhibit glucose intolerance, insulin resistance,
and/or impaired glucose-stimulated insulin secretion (Castillo et al. 2011; Marsili et al.
2011; Medina et al. 2011). Forth, DIO1-3 are all implicated in carcinogenesis because
thyroid hormones regulate the signaling events of differentiation, proliferation, and
apoptosis (Piekielko-Witkowska & Nauman 2011; Casula & Bianco 2012).
1.2.2.4 Selenoproteins responsible for protein quality control
By structural analyses, selenoprotein F (SELENOF, also known as 15-kDa
selenoprotein or Sep15) and selenoprotein M (SELENOM) are categorized as members
of the TXN1-like protein family that possess thiol-disulfide oxidoreductase activity and
control the quality of protein folding in the endoplasmic reticulum (Ferguson et al. 2006).
Furthermore, SELENOF is abundant in the liver, kidney, testis, and prostate of mice and
regulates protein folding through interactions with UDP-glucose:glycoprotein
glucosyltransferase, a chaperon protein (Korotkov et al. 2001; Davis et al. 2012).
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Interestingly, results of Selenof−/− mice suggest an unexpected role of SELENOF in the
promotion and metastasis of colon cancer (Irons et al. 2010). Knockout of Selonom−/− has
developed to express the obesity phenotype. While SELENOM is highly expressed in the
brain and can sequester zinc in the Alzheimer’s brain (Du et al. 2013), Selonom−/− mice
have normal motor and cognitive functions (Pitts et al. 2013). Methionine-R-sulfoxide
reductase 1 (MsrB1), also known as selenoprotein R or X, is another TXN-dependent
protein that reduces the oxidized form of methionine-R-sulfoxide on proteins in the
cytosol and nucleus. MsrB1−/− mice have been developed, and express increased
malondialdehyde, protein carbonyls, methionine sulfoxide, and oxidized glutathione in
the liver and kidney, but not the heart, testis and brain (Fomenko et al. 2009). Studies of
MsrB1−/− mice revealed that MSRB1 is involved in the conservation of reduced
methionine, which supports innate immunity through macrophages (Lee et al. 2013).
1.2.2.5 Other selenoproteins
SELENOP is the major extracellular selenoprotein for Se delivery. Such a primed
role in Se homeostasis is consistent with the unique feature of this selenoprotein, that
contains 10 selenocysteine residues. In fact, SELENOP is the only mammalian
selenoprotein known to have more than one selenocysteine residue. SELENOP is mainly
synthesized in the liver and then secreted to the whole-body via circulation to maintain Se
homeostasis (Burk & Hill 1994; Himeno et al. 1996). In addition to the role in Se
delivery, results from Selenop−/− mice implicate SELENOP in spermatogenesis and the
prevention of brain degeneration (Burk & Hill 2009). SELENOP is also known to bind
zinc and prevent amyloid-β peptide aggregation in the brain (Du et al. 2013), suggesting
a role in Alzheimer’s disease. However, SELENOP may not always accurately
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incorporate selenocysteine in response to UGA because this could be a wobble codon for
either decoding selenocysteine or translation termination. This is evidenced by the
identification of the three shortened SELENOP isoforms that are generated by alternative
termination at the second, third, and seventh UGAs for selenocysteine residues as stop
signals (Burk & Hill 2005). Moreover, selenoprotein W (SELENOW) is mainly
expressed in the muscle, heart, spleen and brain of mammals and is suggested to play
important roles in immune responses and TXN-dependent pathways (Whanger 2009).
Selenoprotein K (SELENOK) (Fredericks et al. 2014) and selenoprotein N (SELENON)
(Arbogast & Ferreiro 2010; Castets et al. 2012) are implicated in calcium homeostasis
and muscle integrity. Biological roles of selenoprotein H (SELENOH) and other nuclear
selenoproteins are discussed below.
1.3 Nuclear Selenoproteins and Functions
Based on biochemical and cellular studies, five selenoproteins present in the
nucleus constitutively, temporarily, or in a tissue-specific manner. These proteins include
are SELENOH, MSRB1, GPX4, TXNRD1, and thioredoxin glutathione reductase (TGR)
(Sun et al. 2001; Kim & Gladyshev 2004; Borchert et al. 2006; Novoselov et al. 2007;
Go & Jones 2010). Only SELENOH is exclusively localized in the nucleus. To provide a
comprehensive scheme of nuclear selenoproteins, for the nuclear localization signal
(NLS) has been searched for (Zhang et al. 2016). As shown in Table 1.2, the results
predicted 10 additional nuclear selenoproteins; however, experimental verification for
these selenoproteins is necessary. For these predictions, the cNLS Mapper program that
takes monopartite and bipartite NLS into consideration was used. This program is
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believed to be more accurate than a few others (Kosugi et al. 2009). SELENOH is the
only selenoprotein to score >10 (monopartite NLS), which denotes nucleus exclusive
localization. MSRB1, SELENOT, and DIO2 are scored between 5 and 10, which denotes
localizations in and the shuttle between nucleus and cytoplasm. Although GPX4,
TXNRD1, and TGR have previously been empirically identified to reside in the nucleus.
The predicted low scores suggest that their appearance in the nucleus is transient,
possibly only under certain circumstances or only certain isoforms are nuclear. On the
other hand, nuclear predictions by cNLS Mapper for the abundant extracellular GPX3
and SELENOP and cytosolic GPX1 (< 2) are consistent with the known non-nuclear
localization of these selenoproteins. Illustration of the positions and types of NLS for
these selenoproteins are specified in Figure 1.1. Based on both experimental and
predicted results, five nuclear selenoproteins are discussed hereafter on the basis of
molecular, cellular, and physiological perspectives. Because a prime function of nuclear
proteins is to maintain genome integrity, genome maintenance is also briefly discussed.
1.3.1 Genome maintenance
Endogenous and exogenous DNA damage constantly hamper genome stability
through forms such as oxidative by-products from mitochondrial respiration, errors in
DNA replication, and environmental stimuli including ultraviolet radiation and prooxidants. Genome maintenance mitigates DNA damage through the detection, signaling
and repair of DNA lesions. The fact that genome instability syndromes are often
associated with cancer, developmental defects, neurodegeneration, premature aging, and
other chronic diseases strongly suggests that genome maintenance is essential for optimal
health and life (Jackson & Bartek 2009). It is clear that selenoproteins and Se metabolites
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play important roles in genome maintenance through mechanisms such as DNA damage
response and epigenetic regulation. It is noteworthy that although both DNA and RNA
are subjecte to damage, it is generally conceived that RNA damage is less of a concern
because transcription is continuous and damaged RNA can simply be degraded.
However, this simplified or even subjective view has been challenged recently, as there is
clear evidence for the existence and biological significance of RNA repair, including
genome stability in the nucleolus (Tsekrekou et al. 2017).
Early detection of DNA damage enables timely cessation of the cell cycle from
progressing into the next phase, which can prevent the replication of mutated DNA when
this occurs in the S phase of the cell cycle. A key molecular signal for recruitment of
DNA repair and checkpoint proteins to sites of damaged DNA is the phosphorylation of
histone H2AX on Ser-137 by ATM and other kinases. In the signal cascade, sensor
proteins first detect DNA damage and subsequently transmit the signal to downstream
sensor kinases. Among these, ataxia-telangiectasia mutated (ATM) is a key kinase in the
early response to DNA damage, chromatin conformational changes, and oxidative stress
(Guo et al. 2010). ATM is activated by autophosphorylation on Ser-1981 in humans or
Ser-1987 in mice, which in turn, activate its downstream targets for cell cycle arrest
and/or DNA repair. Depending on the severity of genome instability, the cell can be fixed
and back to life or become senescent and/or apoptotic cells.
Besides direct damage to nucleic acids, genome instability can also be induced by
adverse changes in histone proteins or chromatin structures. These epigenetic events
include cis-epigenetics that directly methylate or demethylate cytosine bases and transepigenetics that change chromatin accessibility (Bonasio et al. 2010). At CpG
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dinucleotides that surround the transcriptional initiation site, the addition or removal of
methyl groups dictates whether this gene is transcribed or not, respectively. For
chromatin accessibility, this occurs on histone proteins that can be modulated by various
forms of modifications including methylation, acetylation, ubiquitination and/or
phosphorylation. Defects in optimized regulation of these epigenetic events are
implicated in the pathophysiology of a growing list of chronic diseases.
1.3.2 SELENOH
Computational analyses of nuclear localization sequences and results from
cellular and biochemical studies strongly implicate SELENOH as a genuine nucleolar
protein in the nucleus (Table 1.2) (Novoselov et al. 2007; Panee et al. 2007). Through
approaches of 1) cellular localization of SELENOH fused to green fluorescent protein, 2)
western analyses of sub-nuclear fractions, and 3) proteomic analyses of SELENOHassociated proteins. Results strongly suggest localization of SELENOH to the nucleolus
(Novoselov et al. 2007). As evidenced by the presence of an AT-hook motif at the
extreme N-terminus, SELENOH is a member of the high-mobility group HMG family of
DNA-binding proteins (Panee et al. 2007). Proteins in this family bind DNA minor
grooves and specific regulatory DNA sequences, thus regulating various aspects of DNA
metabolism such as DNA repair, replication, and transcription (Grosschedl et al. 1994). A
role of SELENOH as a transactivator is evidenced by results from chromatin
immunoprecipitation experiments that show associations between GFP-SELENOH and
heat shock or stress response elements and up-regulation of genes de novo glutathione
synthesis and phase II detoxification by SELENOH (Panee et al. 2007). Human
SELENOH contains a high amount of basic amino acids (19.7%) (Zhang et al. 2016),
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which is reminiscent of histone proteins and facilitates binding with negatively charged
DNA. Another proposed function of SELENOH is to catalytically regulate redox status.
Structural analyses suggest that SELENOH is a homologue of TXNRD that has a redoxregulatory CXXU motif. Enzymatic analyses show that SELENOH exhibits GPX-like
activity as well (Novoselov et al. 2007).
Results from biochemical and cellular analyses of SELENOH are largely
consistent with those from functional studies. In HT22 neuronal cells, overexpression of
SELENOH protects superoxide formation after UVB irradiation (Ben Jilani et al. 2007).
In mammals, there is differential expression of SELENOH in a manner that is dependent
on tissues and life cycle stage. At the mRNA level, SELENOH expression is high during
embryogenesis and in certain cancer cells such as colorectal HCT116 and prostate
LNCaP cells. Its expression is also high in tissues from the brain, thymus, testis and
uterus in mice (Novoselov et al. 2007). Upon exogenous stimuli, SELENOH mRNA is
up-regulated upon cellular exposure to H2O2 (Wu et al. 2014) or binding of metal
transcription factor-1 to its metal response element (Stoytcheva et al. 2010). Thus,
SELENOH appears to be a sensor of oxidative stress in the nucleolus. Such critical roles
of SELENOH in genome maintenance and redox regulation are consistent with results
from our Lab using cells (Wu et al. 2014) and other researchers using zebrafish (Cox et
al. 2016). Collectively, SELENOH may interact with ATM, p53, and ROS to function in
replicative senescence, embryogenesis, and carcinogenesis
1.3.3 MSRB1
Methionine-R-sulfoxide is an oxidized product on proteins but can be catalytically
reversed to methionine by MSRB1. While mammalian MSRB1 is primarily located in the
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cytosol and nucleus, the cysteine-containing non-selenoproteins MSRB2 and MSRB3 are
present in the mitochondria and endoplasmic reticulum (Kim 2013). Altogether, the
MSRB system reduces oxidized proteins in various cellular compartments. However,
MSRB1 does not seem to universally repair methionine-R-sulfoxide on proteins because
it is known to selectively target certain proteins such as actin. In Msrb1−/− mice, innate
immunity is repressed and actin polymerization is disrupted in the macrophages (Lee et
al. 2013). This suggests that MSRB1 may target methionine-R-sulfoxide on actin and
maintain genome stability in the nucleus, which is plausible considering the fact that
nuclear actin can regulate gene expression and chromatin remodeling upon extracellular
stimuli (Vartiainen et al. 2007).
MSRB1 was initially identified with the use of bioinformatic tools in 1999 and
named selenoprotein R or selenoprotein X (Kryukov et al. 1999; Lescure et al. 1999).
MSRB1 contains zinc and is expressed mainly in the liver, and to a less extent, in the
kidney and prostate in mice (Novoselov et al. 2010). Although MSRB1 is not detectable
in all parts of the brain using Western analysis, this selenoprotein is selectively expressed
in the hippocampus and cerebellar cortex in mice (Zhang et al. 2008). Interestingly,
consumption of supranutritional Se at 3-fold greater than nutritional needs results in a
substantial increase in hepatic MSRB1 protein level and activity in a mouse model of
hepatic carcinogenesis (Novoselov et al. 2005). This is atypical for selenoprotein because
expression of most selenoproteins reaches a plateau at nutritionally adequate levels.
1.3.4 GPX4
As described above, GPX4 differs from GPX1-3 and GPX6 in protein structures
(monomer vs. tetramer) and substrate preferences (lipid peroxides vs. H2O2) (Labunskyy
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et al. 2014). Furthermore, one of the three isoforms of GPX4 locates to the nucleus.
Alternative splicing of GPX4 mRNA results in translation products of the mitochondrial
mGPX4, the cytosolic cGPX4, and the nuclear nGPX4. Expression of these GPX4
isoforms is in a tissue-specific. Although mGPX4 and nGPX4 are found only in testis,
cGPX4 is present in various somatic and embryonic tissues (Schneider et al. 2006a). The
function of GPX4 in the nucleus is not fully understood, but it is known that chromatin in
the caput epididymis of nGPX4 knockout mice is more relaxed, suggesting that GPX4
can regulate chromatin compactness (Conrad et al. 2005). Furthermore, nGPX4
catalytically reduces the DNA-binding protamine and increase its linkage with histone
proteins through disulfide cross-linking (Pfeifer et al. 2001). GPX4’s function of limiting
chromatin accessibility seems to be attributed to its structural roles and not peroxidase
activity (Ursini et al. 1999). Altogether, testicular nGPX4 may inhibit gene expression
through epigenetic mechanisms in a manner depending on its general structural
interactions with chromatin instead of the specific recognition of target DNA sequences.
To date, GPX4 is one of the three selenoproteins that are essential, based on the
observations of embryonic lethality in Gpx4−/−, Txnrd1−/−, and Txnrd2−/− mice (Yant et
al. 2003; Conrad et al. 2004; Jakupoglu et al. 2005). Interestingly, knockout of DIO3
renders the mice partially lethal during embryogenesis (Hernandez et al. 2006). To
circumvent the limitation of embryonic lethality in the whole body and full Gpx4 gene
knockout, GPX4 isoform-specific and tissue-specific conditional knockout mice have
been generated to understand physiological functions of these three GPX4 isoforms. It is
hypothesized that not all of these three GPX4 isoforms are essential. With the use of
these sophisticated mouse models, it has been shown that 1) spermatocyte-specific Gpx4
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or mGpx4 knockout results in male infertility (Imai et al. 2009; Schneider et al. 2009),
and 2) nGpx4 knockout mice are viable and fertile (Conrad et al. 2005). These results
collectively suggest that cGPX4 and mGPX4 are essential for embryogenesis and
fertility, respectively; however, the proposed epigenetic role of nGPX4 in the regulation
of chromatin condensation may not be necessary for male fertility or survival. Mice
overexpressed with GPX4 had less liver apoptosis that was induced by tbutylhydroperoxide and diquat (Ran et al. 2004). Paradoxically, the lifespan of Gpx4+/−
mice is slightly longer (7%, 1029 vs. 963 days, P < 0.05) than that of Gpx4+/+ control
mice (Ran et al. 2007). This unexpected role of GPX4 in lifespan is consistent with our
recent results that show that long-term dietary Se deficiency increases (P < 0.05)
longevity by 4 and 7 % in male and female mice with humanized telomeres, respectively
(Wu et al. 2017). Nonetheless, it is of future interest to elucidate the nuclear function of
GPX4 in various tissues and during the life cycle.
1.3.5 TXNRD1 and TGR
After protein disulfides are reversed by reduced TNX, oxidized TXN can only be
recycled by the three TXNRN members of selenoproteins. TXNRD1, TXNRD2, and
TGR are encoded by Txnrd1, Txnrd2 and Txnrd3, respectively (Tamura & Stadtman
1996; Miranda-Vizuete et al. 1999; Sun et al. 1999). TGR is unique because it carries
both glutaredoxin and TXN-fold domains (Su et al. 2005). Although TXNRD1 is present
in mitochondrion and cytosol and TGR is mainly expressed in microsome, results from
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Se-labeled proteins demonstrated that a portion of TXNRD1 and TRG is localized to

the nucleus in mouse testis (Sun et al. 2001). Although the functional significance of
TGR localization in the nucleus is unknown, genetic analyses clearly suggest that
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TXNRD1 has important roles in the nucleus. Isoforms of TXNRD1 exist as a result of
alternative splicing and localize to various cellular localizations. Through the approach of
rapid amplification of TXNRD1 cDNA, cytosolic TXNRD1b is known to bind to the
nuclear receptors, estrogen receptor- and -β through its LXXLL motif (Rundlof et al.
2004), which, in turn, induces translocation of this selenoprotein to the nucleus for
modulation of estrogen signaling (Damdimopoulos et al. 2004). Another functional
implication of TXNRD1 in the nucleus is evidenced by studies with the use of embryos
from Txnrd1−/− mice, in which nonfunctional oxidized ribonucleotide reductase is
expressed and DNA synthesis is impaired (Jakupoglu et al. 2005). Although the
mechanisms are unclear, this suggests TXNRD1 has critical roles in the regulation of
DNA metabolism. Members of the TXNRD family also indirectly participate in genome
maintenance through post-translational regulation of nuclear proteins including NF-κB,
AP-1, p53 and glucocorticoid receptor (Arner 2009; Lu & Holmgren 2009). The transient
and isoform-specific nature of these two selenoproteins indicates that the contribute to the
regulation of genome stability. However, the mechanism by which they translocate
intracellularly and how they mediate downstream targets in response to various stimuli
remains to be elucidated.
1.3.6 Selenoprotein expression at supranutritional level in mice and supplemental Se
in cells
Although it was previously reported that selenoprotein expression is saturated at
the nutritional level, this simplified view is challenged by a strong body of recent
evidence. Supranutritional Se up-regulates a couple of selenoproteins, such as MSRB1
activity in TGF/c-Myc mice with hepatic tumors (Novoselov et al. 2005; Novoselov et
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al. 2010) and SELENOH protein in the liver of healthy pigs (Liu et al. 2012).
Supranutritional selenized yeast containing Se at 3-4 fold higher than nutritional needs,
with 20 Se-containing chemicals was efficacious at cancer prevention in human study
(Clark et al. 1996). Supplementation of supranutritional or toxic levels of a single Se
species such as selenite induced diabetes in animals (Zhou et al. 2013). Clearly, the
pathogenesis of cancer and diabetes differ, but Se speciation is also critical for health
outcomes and this may also be explained from the perspective of Se regulation of
epigenetics (Cheng et al. 2014). Previous studies on Se nutrition mainly employed animal
models. Cell cultures were considered inappropriate in this regard because fetal bovine
serum, an essential component for cell culture medium, may contain sufficient Se to
saturate selenoprotein expression. In addition to selenoproteins, supplemental Se clearly
regulates other proteins. In HCT116 colon and LNCaP prostate cancer cells that were
supplemented with Se compounds at above the nutritional level, DNA methyltransferase
(DNMT) activity and DNMT-1 protein expression were reduced (Fiala et al. 1998; Xiang
et al. 2008). Similarly, supranutritional Se in rats suppresses global DNA methylation
(Zeng et al. 2011). Epigenetic regulation of supplemental or supplemental Se impacts not
only DNA methylation but also histone modifications. Se compounds are known to
activate histone H3 acetylation in a rat model of colorectal carcinogenesis and histone
H2AX phosphorylation in colorectal cancer cells, but inhibits histone deacetylase activity
in B-cell lymphoma (Qi et al. 2010; Kassam et al. 2012; Hu et al. 2013). In addition to
the modulation of histone proteins, we have previously demonstrated that Se compounds
at sub-lethal doses (< LD50) can activate ATM-dependent DNA damage for senescence
response in non-cancerous cells but not in cancerous cells (Qi et al. 2010; Wu et al.
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2010). Since a senescence response is a hallmark of early tumorigenesis barrier, this
provides a clue as to how supranutritional Se can inhibit cancer growth in some clinical
studies (Clark et al. 1996; Wu et al. 2010). It is intuitive to speculate that nuclear Se or
selenoproteins confer such roles of Se in genome maintenance.
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1.4 Figures and Tables
Table 1.1
Gene
Mutations
SECISBP2
R540Q/R540Q

SECISBP2
p.M515fsX563/
p.Q79X
SECISBP2
P1:fs255X
P2:C691R

SEPSECS
Y429X/T325S
SEPSECS
Y443C/Y443C
Y443C/A239T

Human diseases linked to inborn gene mutations in association with
selenoprotein synthesis
Phenotypes
Missense

Abnormal thyroid function
tests (TFT), short stature,
delayed bone age, normal
mental development

Nonsensemediated mRNA
decay/Premature
termination
P1:Frameshift
premature stop
mutation.
P2:Missense

Mild mental retardation,
pervasive
development disorders,
hypoplastic thyroid gland
Abnormal TFT,
azoospermia, muscular
dystrophy, photosensitivity,
abnormal cytokine
secretion, and telomere
shortening and replication
stress in T lymphocytes

Missense, with
residual activity,
truncation
Missense

Cortical laminar necrosis,
loss of myelin and neurons,
and astrogliosis
PCH2D, PCCA,
microcephaly, spasticity,
seizures.
Autosomal recessive
symptoms of progressive
cerebellocerebral atrophy
Intellectual disability,
developmental delay

SEPSECS
D489V/D489V
SEPSECS
TRU-TCA1-1
C65G/C65G

Reduced mutant
transcript levels

Abdominal pain, fatigue,
muscle weakness

Selenium/Selenoprotein
deficiency
Low plasma Se, low
plasma
SEPP1, low GPX3, low
DIO2 activity in
fibroblasts
Extremely low levels of
plasma Se, GPX and
SELENOP

Reference

Low plasma Se,
SELENOP and GPX3; low
mGPX4, TXNRD3 and
SELENOV in seminal
plasma; low SELENON,
MSRB1, and GPX1
protein, and SELENOH,
SELENOW, and
SELENOT mRNAs in
fibroblasts.
Low GPX1, GPX4
TXNRD1 in brain

(Schoenmakers
et al. 2010)

Heterologous
complementation assay

(Agamy et al.
2010)

(Dumitrescu et
al. 2005)

(Hamajima et
al. 2012)

(Anttonen et
al. 2015)

(Makrythanasis
et al. 2014)

Low plasma Se. Low
SELENOP, GPX3 in
plasma. GPX1 in
fibroblasts. SELENOW
mRNA in fibroblasts.

(Schoenmakers
et al. 2016)

Mutations in SECISBP2, SEPSECS and TRU-TCA1-1 distinctly results in an array of
phenotypes and selenoprotein deficiency. Of note, they are not selenoprotein genes but
they encode proteins necessary for selenoprotein synthesis.
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NP_003000
NP_002074

SELENOW
GPX2
GPX4

Selenoprotein W

Glutathione peroxidase 2

Glutathione peroxidase 4b

Thioredoxin/glutathione reductase
Glutathione peroxidase 6
Iodothyronine deiodinase 1

NP_443115
NP_874360
NP_000783

114112
257202
1733

2879

2877

6415

7296

58515
57190
55829
85465

51734

1734
51714

280636

Gene ID

NLS type
Monopartite
Bipartite
Monopartite
Monopartite
Bipartite
Bipartite
Monopartite
Bipartite
Bipartite
Bipartite
Bipartite
Bipartite
Bipartite
Bipartite
Bipartite
Bipartite
Bipartite
Bipartite
Bipartite
Bipartite
Bipartite

Predicted NLS
3 PRGRKRKAEA
73 KPRRGSFEVTLLRPDGSSAELWTGIKKGPP
264 KRUKKTRLA
24 GGVPSKRLKMQY
34 RSKYAHSSPWPAFTETIHADSVAKRPEH
63 RSEALKVSCGKCGNGLGHEFLNDGPKPGQSRF
42 LQQDVKKRRSY
23 PPRRRARSLALLGALLAAAAAAAVRVCARH
151 RKSDRKPLRGGGYNPLSGEGGGACSWRPGRRGP
14 GFDKYKYSAVDTNPLSLYVMHPFWNTIVKV
29 KEAAQYGKKVMVLDFVTPTPLGTRWGL
462 KKQLDSTIGIHPVCAEVFTTLSVTKRSG
21 QLKKKLEDEFPGRLDICGEGTPQATGFFE
59 SKKKGDGYVDTESKFLKLVAAIKAALA
4 IAKSFYDLSAISLDGEKVDFNTFRGRAVLI
142 WSPVRRSDVAWNFEKFLIGPEGEPFRRYSRT
5 RLCRLLKPALLCGALAAPGLAGTMCASRDDWRC
151 PKGKGILGNAIKWNFTKFLIDKNGCVVKRY
10 GPGKAGDAPNRRSGHVRGARVLSPPGRRAR
171 WEPMKVHDIRWNFEKFLVGPDGVPVMHWFH
25 VGKVLLILFPDRVKRNILAMGEKTGMTRNP

Score
13
3.7
5.5
5.5
5.4
3.4
4.5
4.3
3.4
3.2
2.2
3.1
3
2.8
2.8
2
2.4
2.6
2.6
2.4
2.1
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In accordance with the input format of cNLS Mapper (36), selenocysteine (U) is substituted by cysteine (C) for amino acid input.
Two types of NLS, monopartite and bipartite, are searched against the 25 selenoproteins. Monopartite is considered more accurate
than bipartite (90% vs. 80%) in predicting NLS (36). Selenocysteine residues are not located in NLS except for Iodothyronine
deiodinase type II. The scores are denoted
as:>10, nucleus only; 8–10, mainly nucleus; 2–8, partial nucleus;<2, non-nucleus.
b
Nuclear presence being verified by experimental evidence.

a

NP_877419

TXNRD1

Thioredoxin reductase 1b

TXNRD3
GPX6
DIO1

NP_067060
NP_996809
NP_060915
NP_277040

SELENOK
SELENON
SELENOS
SELENOI

Selenoprotein K
Selenoprotein N
Selenoprotein S
Selenoprotein I

NP_002076

NP_057416

MSRB1

methionine sulfoxide reductase B1b

b

NP_054644
NP_057359

DIO2
SELENOT

Iodothyronine deiodinase 2
Selenoprotein T

Selenoprotein H

NP_734467

Protein ID

SELENOH

b

Gene symbol

Hierarchy human nuclear selenoproteins predicted by cNLS Mapper

Selenoproteins

Table 1.2

Figure 1.1

Locations and types of NLS (monopartite and/or bipartite) on the nuclear
selenoproteins as predicted by cNLS Mapper. Selenoproteins are listed in
descending order of the likelihood to appear in the nucleus (see Table 1.2
for details).
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SELENOPROTEIN H MAINTAINS GENOME STABILITY IN THE
NUCLEOLUS BY REGULATING REDOX HOMEOSTASIS
AND SUPPRESSING DNA DAMAGE
2.1 Abstract
Selenoprotein H (SELENOH) is a nucleolar oxidoreductase with DNA binding
properties whose function is not well understood. To determine the role of SELENOH in
genome maintenance, a knockout of SELENOH was generated in cell lines using
CRISPR/Cas9-mediated genomic deletion. Based on the sequenced genome, results of
deduced protein sequences indicated various forms of mutants in the CRISPR/Cas9mediated knockout including a frame-shift by aberrant splicing and truncated SELENOH
by early termination of translation. Loss of SELENOH in HeLa cells induced slow cell
proliferation, the formation of giant multinucleated cells, accumulation of unrepaired
DNA damage and oxidative stress, and cellular senescence. The nuclei within SELENOH
cells were enlarged and possessed a single large nucleolus. Atomic force microscopy
results indicated increased stiffness in the nucleoli of SELENOH knockout cells,
suggesting that SELENOH maintains the flexible structure of the nucleolus. Furthermore,
SELENOH knockout led to a large-scale reorganization of nucleolar architecture with the
movement of nucleolar protein into nucleolar cap regions in response to oxidative stress.
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This nucleolar reorganization is dependent on ATM signaling. Altogether, these results
suggest that SELENOH appears to be a sensor for oxidative stress and contribute to redox
regulation and genome maintenance in the nucleolus.
2.2 Introduction
Se exerts many of its physiological functions through selenoproteins. In 2003, it
was concluded that the human genome harbors 25 selenoprotein genes (Kryukov et al.
2003). Selenoproteins contain the 21st amino acid, selenocysteine (Sec), with the use of a
specialized mechanism to recode the otherwise stop codon UGA. The single letter
abbreviation of Sec is U. Since 2003, many of selenoproteins have been studied, but the
functional and physiological roles of selenoprotein H (SELENOH) has not yet been
elucidated.
SELENOH was initially identified in the Drosophila melanogaster genome,
which encodes the BthD protein (Martin-Romero et al. 2001), and subsequently, its
homologs were found in the human and mouse genomes (Kryukov et al. 2003; Morozova
et al. 2003). SELENOH expression is high in the brain, during embryogenesis, and in the
nucleolus. The human SELENOH gene is found in open reading frame 31 on
chromosome 11. The SELENOH gene contains 3 exons and 3 introns, totaling 2305 base
pairs (bp). Based on the NCBI database, there are two transcript variants for SELENOH:
transcript variant 1 (1448 bp, NM_170746) and transcript variant 2 (1428 bp,
NM_001321335) (Figure 2.2). Since the length difference is located to the 3`untranslated region, both variants encode the same SELENOH with 122 amino acids. Sec
is located at position 44 and within the CXXU (CTSU) motif of this 14-kDa
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selenoprotein. SELENOH also has a conserved nuclear targeting RKRK motif in the Nterminal sequence. SELENOH has a unique subcellular localization pattern that is
specific to the nucleoli (Novoselov et al. 2007). Expression of SELENOH is relatively
low in adult mouse tissues but is high during embryonic development and in certain
cancer cell lines. SELENOH is one of the few selenoproteins whose expression is
sensitive to dietary Se fluctuations (Howard et al. 2013). SELENOH contains an AThook motif, and may potentially serve as a redox sensor that functions in conjunction
with some of the redox-responsive transcription factors (Panee et al. 2007).
Overexpression of SELENOH protects HT22 mouse hippocampal neuronal cells from
UVB irradiation-induced death through the reduction of superoxide formation,
mitochondrial depolarization, and cell survival (Ben Jilani et al. 2007; Mendelev et al.
2009). Furthermore, overexpression of SELENOH in HT22 cells promotes mitochondrial
biogenesis and improves mitochondrial functional performance (Mendelev et al. 2011).
Furthermore, a recent study indicates that SELENOH as an essential regulator of redox
homeostasis that also interacts with p53 in development and tumorigenesis (Cox et al.
2016). SELENOH also contributes to the suppression of senescence and DNA damage
responses to oxidative stress in the presence of ATM kinase and p53 (Wu et al. 2014),
which suggested that this nucleolar selenoprotein as a gatekeeper protein for genomic
integrity.
Our preliminary studies have demonstrated that depletion of SELENOH leads to a
mitotic defect that results in slow proliferation and multinucleation in HeLa cells. Such
failure in proper mitotic progression is associated with disruption of genomic integrity.
These observations suggest that SELENOH may play an important role in response to the
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DNA damage in mitosis. Furthermore, loss of SELENOH results in significant changes in
nucleolar morphology and nucleolar organization. In order to address this hypothesis,
SELENOH knockout models were produced in cells in order to study the functions of
SELENOH in cell cycling control and genome stability within the nucleolus. SELENOH
knockout cell lines were constructed by the CRISPR/Cas9 technology. Biallelic mutants
were selected by single colony screening and genomic DNA sequencing.
2.3 Materials and Methods
2.3.1 Cell culture and chemicals
The HeLa human cervix carcinoma cells and HEK 293T human embryonic
kidney cells were cultured in Dulbecco’s modified Eagle’s medium (DMEM, Gibco,
Thermo Fisher Scientific, Karlsruhe, Germany) with high glucose that was supplemented
with 10% fetal calf serum (FCS, Gibco), 100 U/mL penicillin and 100 g/mL streptomycin
(Sigma-Aldrich, Taufkirchen, Germany) at 37 ºC with 5% CO2.
2.3.2 Generation of SELENOH knockout transfer constructs by CRISPR/Cas9
system
To knock out SELENOH using the CRISPR/Cas9 technology, two single guide
RNA (sgRNA) oligonucleotides, SELENOH-CR1 and SELENOH-CR2 (Figure 2.2),
were chosen to target the SELENOH gene with the use of publicly available on-line tools
(Cong & Zhang 2015) to reduce the likelihood of off-target cleavage. CRISPR/Cas9
constructs for the SELENOH knockout were generated as described previously in the
Zhang laboratory (Sanjana et al. 2014). Briefly, lentiCRISPRv2 plasmid (5 µg, Addgene
plasmid #52961, Cambridge, MA) was digested and dephosphorylated with Fermentas
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FastDigest BsmBI (3 units) and FastAP thermosensitive alkaline phosphatase (3 units,
Thermo Fisher Scientific) at 37 ºC for 30 min in a 60 µL reaction mixture that contained
1X FastDigest Buffer and 1 mM DTT. The digested plasmid was gel purified with the use
of a DNA Gel Extraction Kit (Thermo Fisher Scientific). To introduce BsmBI cloning
site, the CACC and AAAC sequences were added at 5′ end to the sense and anti-sense
sgRNA-specifying oligo sequences, respectively (sense sequence: SELENOH-CR1,
CACCGCACTAGCTGACGCGTCTAT; SELENOH-CR2,
CACCGTCGTCGGGTTCACCTTTAC; anti-sense sequence: SELENOH-CR1,
AAACGATAGACGCGTCAGCTAGTG; SELENOH-CR2, AAACGTAAAG
GTGAACCCGA CGAC). Next, the two complementary guiding nucleotides (10 µM)
were phosphorylated and annealed in a 10 µL mixture that contained 1X T4 DNA Ligase
Reaction Buffer (New England Biolabs, Ipswich, MA), ddH2O (6.5 µL), and T4
polynucleotide kinase (0.5 µL, New England Biolabs) at 37 ºC for 30 min, 95 ºC for 5
min, and then ramping down to 25 ºC at 5 ºC /min. Next, annealed duplex DNA (0.5 µM)
was cloned into linearized lentiCRISPRv2 plasmid (50 ng) in a mixture containing 1X
Quick Ligase Buffer (New England Biolabs), Quick Ligase (1 µL, New England
Biolabs), and ddH2O (to a total of 11 µL). After incubation at room temperature for 10
min, the ligated lentiCRISPRv2 constructs were transformed into GCI-L3 competent cell
(GeneCopoeia, Rockville, MD). Selected colonies were analyzed by plasmid isolation
and sequencing. The lentiCRISPRv2 construct was ligated with a non-target guiding
RNA duplexes as a negative control (5′-CGCGATAGCGCGAATATATT-3′) (Perez et
al. 2015).
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2.3.3 Packaging of lentiviruses
To prepare lentiviruses for SELENOH knockout, the lentiCRISPRv2 SELENOHCR1 and SELENOH-CR2 transfer constructs were co-transfected with the packaging
plasmids pCMV-VSV-G and psPAX2 (Addgene plasmids #8454 and #12260). 293FT
cells (Thermo Fisher Scientific) at 70-80% confluency in 6-well plates were transfected
with the transfer construct (0.75 µg) and the pCMV-VSV-G (0.56 µg) and psPAX2 (1.69
µg) packing plasmids in lentivirus packaging medium (Opti-MEM with GlutaMAX that
was supplemented with 5% FBS and 1mM sodium pyruvate, Invitrogen) in the presence
of Lipofectamine 3000 Transfection Reagent (7 µL) and P3000 Enhancer Reagent (6
µL). Cell culture medium was replaced by pre-warmed lentivirus packaging medium at
6h post-transfection. At 24 h post-transfection, the cell medium was centrifuged at 2,000
 g for 10 min at room temperature and filtered with the use of a 45 µm polyethersulfone
low protein binding membrane (Millipore) to remove cell debris. Next, 1 volume of
Lenti-X concentrator (Clontech, Mountain View, CA) was mixed with 3 volumes of the
filtered supernatant by gentle inversion, followed by incubation at 4 ºC for 30 min and
centrifugation at 1,500  g and 4 ºC for 45 min. After the supernatants were removed, the
pellets were re-suspended in complete DMEM to 1/10 of the original volume and stored
at -80 ºC in single-use aliquots.
2.3.4 Generation of SELENOH knockout cells
HeLa and HEK293T cells were plated in a 24-well plate (2  104 cells per well)
for 24 h prior to infection of lentiviruses carrying the lentiCRISPRv2 SELENOH
knockout constructs in the presence of polybrene (6 µg/mL, Millipore, Billerica, MA) for
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12 h at 37 ºC with 5% CO2. Two days after recovery from the infection, sgRNA/Cas9
positive cells were screened with the use of puromycin (2 µg/mL, Goldbio, Olivette,
MO). Two weeks later, the cells were expanded to three 35-mm dishes. SELENOH
knockdown efficiency was assessed with the use of quantitative real-time polymerase
chain reaction (RT-qPCR).
2.3.5 RT-qPCR analysis
Total RNA was isolated with the use of RNeasy Mini Kits (Qiagen, Hilden,
Germany). DNA was removed by on-column DNase digestion using RNase-free DNaseI
(Invitrogen, Rockville, MD). One µg of DNaseI-treated RNA was (5 µg of RNA/unit
DNaseI) reversely transcribed to cDNA by using the High Capacity cDNA synthesis kit
(Thermo Fisher Scientific). All PCR reactions were performed in 10 µL with the use of
an SYBR Green Super Mix (Bio-Rad, Hercules, CA). Reactions were performed in an
ABI Prism 7500 Fast Sequence Detection System (Thermo Fisher Scientific) with the
following conditions: 95 °C for 30 sec, 40 cycles at 95 °C for 15 sec, and then 60 °C for
30 sec. A dissociation curve was run for each plate to confirm the production of single
products. SDS software was used to quantitate data by using the ΔΔCt method and βactin mRNA (ACTB) as an internal control. The following gene-specific primers were
used for RT-qPCR reactions in this study:
sense sequence: HSH_CR1_F, CATTGCACTAGCTGACGCGTCTATG;
HSH_CR2_F, GTAGCCGAGAAGCGAGAGAAGCTGG;
Actin_F, CACTCTTCCAGCCTTCCTTCCTGG;
anti-sense sequence: HSH_CR1_R, CTTCTTAATCCCAGTCCAGAGCTCC;
HSH_CR2_R, GGCTTCGTCGGGTTCACCTTTACTGG;
37

Actin_R, TCCTTCTGCATCCTGTCGGCAATGC.
The HSH_CR1_R and HSH_CR1_F primers for CR1 were targeted SELENOH
exon 3 and the junction of SELENOH exons 1 and 2, respectively (Figure 2.1). The
HSH_CR2_F and HSH_CR2_R primers for CR2 targeted SELENOH exon 1 and exon 2,
respectively (Figure 2.1). Such designs excluded the possibility to detect genomic DNA
(Hsu et al. 2011). The specificity of each primer pair was verified by PCR with the use of
recombinant plasmid DNA that contained SELENOH.
2.3.6 Cell growth assay
To assess the impact of SELENOH knockout on cell proliferation, cells infected
with SELENOH-CR1 and SELENOH-CR2 knockout and non-targeting constructs were
grown in 6-well plates and counted daily with the use of a hemocytometer until they
reached ~ 2  106 cells/mL or no longer grew logarithmically.
2.3.7 Clonal selection
Cells were counted and seeded into 96 well plates through serial dilution starting
from 4,000 cells/well to about one cell/well. After 7-10 days of expansion, wells that
contained only a single colony were marked. These colonies were transferred into 24well plates and cultured with fresh media. Genomic DNA was extracted by re-suspension
of the cells in an extraction buffer (10 mM Tris-HCl, pH 8.0, 1 mM EDTA, 0.2 mg/mL
protease K, 20 µg/mL RNaseA), incubation at 55 °C for 30 min, and purification by the
phenol-chloroform method. RNA isolation and cDNA synthesis were performed with the
use of RNeasy Mini Kits (Qiagen) and the High Capacity cDNA synthesis kit (Thermo
Fisher Scientific), respectively. SELENOH genomic DNA and cDNA were separately
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amplified by Phusion Hot Start II DNA Polymerase (Thermo Fisher Scientific). Fifty μL
PCR reactions were carried out in 1 μL Phusion Hot Start II DNA Polymerase, 5X
Phusion HF buffer, 200 μM dNTPs each, and 0.2 μM HSH_CDS_F and HSH_CDS_R
primers (Figure 2.1)
(HSH_CDS_F, CTTCCTTTGAGAGAGGTTTCCGCTG,
HSH_CDS_R, TACAATGCCTTACTAGAGGGTTGCCTC), with cycling
conditions of 98 °C for 3 min, 35 cycles of 98 °C for 10 s, 72 °C for 45 s, and a final
extension of 72 °C for 5 min. Amplicons were sliced out from a 1% (w/v) agarose gel,
purified with a DNA Gel Extraction Kit (Thermo Fisher Scientific), the PCR products
were A-tailed and then cloned into a pGEM-T easy vector (Promega). At least 10 clones
for each colony were picked and cultured in LB medium that contained 50 μg/mL
ampicillin and was agitated at 200 rpm and 37°C overnight. Plasmid DNA was isolated
using a Plasmid Miniprep Kit (Thermo Fisher Scientific) and subjected to Sanger
sequencing with M13F and M13R sequencing primers from Eurofins Genomics
(Louisville, KY). Sequences were analyzed by Blast (NCBI, Bethesda, MD) with the use
of SELENOH genomic NC_000011.10 (region: 57741250-57743554) and transcript
NM_170746.3 as references. The ExPasy tool “Translate” was used to predict the
consequences of the observed nucleotide changes (Kapahnke et al. 2016).
2.3.8 Scoring cell, nuclei, and nucleolar size/number
HeLa cells were seeded onto coverslips and fixed in pre-chilled 100% methanol at
-20°C for 10 min. Coverslips were incubated with the cell-permeable SYTO RNASelect
Green Fluorescence Cell Stain (500 nM, Thermo Scientific Scientific) for 20 min at
37°C, washed and mounted onto glass slides by using ProLong Gold antifade mountant
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with DAPI (Thermo Scientific Scientific). The area of an individual cell or clustered cells
were traced and scored with the use of freehand measurement tools of ImageJ software
(NIH). Areas cross-sectioned with nuclei and nucleoli were measured. Nucleoli were
counted by SYTO RNASelect staining. A contrast threshold was applied to micrographs
to allow for the semi-automated, unbiased measurement of nucleolar area and number by
using the wand (tracing) tool of ImageJ software.
2.3.9 Cell cycle analysis
Control or SELENOH knockout HeLa cells were subjected to cell cycle analysis.
Briefly, 3 × 106 cells were fixed with cold ethanol (70%) for 1 hr, centrifuged,
resuspended and incubated in PBS containing RNase A (0.2 mg/mL, Thermo Fisher
Scientific) and Propidium Iodide (10 µg/mL, Roche Diagnostics GmbH, Indianapolis,
IN) for 20 min, and analyzed immediately by flow cytometry. The channel FL2 was used
to analyze 50,000 events per condition. Gated cells were manually categorized into cell
cycle stages. Cell cycle analysis was performed using Flowjo V10 software (Treestar,
Inc.).
2.3.10 Cellular glutathione peroxidase (GPX) activity
Cells were harvested by rubber policemen, washed twice with cold PBS, collected
cells by centrifugation (1,000  g for 10 min at 4 °C), homogenized in 200 µL ice-cold
buffer (50 mM Tris-HCl, pH 7.5, 5 mM EDTA, and 1 mM DTT), and centrifuged
(20,000  g for 10 min at 4°C) twice. The supernatant was stored on ice for immediate
measurement of GPX activity according to the manufacturer's protocol (Cayman
Chemical, Ann Arbor, MI, USA). Cumene hydroperoxide was used as a GPX substrate in
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the presence of glutathione (GSH) to generate oxidized GSH (GSSG). The rate of
NADPH consumption by glutathione reductase in the subsequent reduction of GSSG was
determined spectrophotometrically by a Synergy HTX plate reader (BioTek Instruments,
VT) and used to calculate GPX activity. GPX activity was expressed as units per mg
protein determined by the Pierce BCA protein assay (Thermo Scientific Scientific).
2.3.11 Thioredoxin reductase (TXNRD) activity
TXNRD activity was quantified using a thioredoxin reductase assay kit (Cayman
Chemical, Ann Arbor) based on the measurement of gold-inhibited NADPH dependent
DTNB reduction by a Synergy HTX plate reader (BioTek Instruments, VT). Cells were
harvested by rubber policemen and homogenized in a potassium phosphate buffer (50
mM) that contained 1 mM EDTA (pH 7.4). TXNRD activity per minute was estimated as
the difference between the reducing activity of the sample in the absence and presence of
gold thioglucose, followed by normalization against total protein concentration as
determined by the Pierce BCA protein assay (Thermo Scientific Scientific). TXNRD
activity was analyzed in duplicates for each sample in four independent experiments.
2.3.12 Protein oxidation
Protein carbonyl content was measured using a protein carbonyl assay kit
(Cayman Chemical, Ann Arbor) that was based upon a DNPH reaction. Cells were
harvested by rubber policemen and homogenized in an MES buffer (50 mM) that
contained 1 mM EDTA (pH 6.7). The supernatant was clarified by centrifugation at
10,000  g for 15 min and 4 °C. Followed by incubation at 25°C for 15 min with
streptomycin sulfate (1% v/v). After centrifugation at 6,000  g for 10 min and 4°C,
41

protein carbonyl content was measured with the use of a Synergy HTX plate reader
(BioTek Instruments, VT). Calculation of the carbonyl content was performed by using a
molar absorption coefficient of 22 mmol/L per cm.
2.3.13 Identification of senescence cells
Cells were plated at 0.3 × 106 cells per well in 6-well plates overnight, washed
twice in PBS, fixed at 25°C with 3% formaldehyde for 5 min, and washed twice with
PBS. Senescent cells were assessed with the use of a senescence-associated βgalactosidase kit (BioVision, Milpitas, CA) according to the manufacturer’s protocol.
Cells were then visualized at 40× magnification under an inverted microscope (Wilovert
A, Hund, Wetzlar, Germany) with bright field illumination. Senescent cells that stained
blue were counted in a blinded-manner using 15 different microscopic fields for each
sample.
2.3.14 Western blotting analysis
The soluble fraction was prepared by lysing the cells in ice-cold RIPA buffer that
contained protease inhibitors cocktail and sodium orthovanadate (Santa Cruz Biotech,
Santa Cruz, CA) for 30 min, centrifuging at 10,000  g for 30 min at 4 °C, separating
proteins using 12% SDS-PAGE, and transferring to PVDF membranes (Bio-Rad Lab.,
CA). The membranes were blocked with a solution containing 5% bovine serum albumin
for 1 h and then incubated separately overnight at 4 °C with primary antibodies (pATM
Ser1981, 1:5000, 2152-1, Epitomics, Burlingame, CA), γH2AX (phosphor-H2AX on
Ser-139, 1:2000, 05-636, Upstate, Charlottesville, VA), ATM (1:2000, sc-23931, Santa
Cruz Biotech.), UBF (1:2000, sc-13125, Santa Cruz Biotech.), C23 (1:2000, sc-8031,
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Santa Cruz Biotech.) and β-actin (1:2000, sc-8432, Santa Cruz Biotech.) at 4 °C. This
was followed by incubation with HRP-conjugated secondary antibodies (Santa Cruz
Biotech.) for 1 h at 25°C. An enhanced chemiluminescence detection kit (Bio-Rad Lab.,
CA) was used for signal acquisition by Chemidoc XRS+ Imaging System (Bio-Rad Lab.,
CA). The quantification of the bands was conducted using Image Lab (Bio-Rad Lab.,
CA).
2.3.15 Measurement of nucleolar stiffness by atomic force microscopy (AFM)
Cells were treated with or without H2O2 (1 mM) for 15 min. Nucleoli were
fractioned from HeLa cells as previously described (Hacot et al. 2010). Isolated nucleoli
were seeded on a 0.01% poly-L-lysine-coated slide for 30 min in sucrose buffer (0.25 M)
and measured at room temperature with the use of a Bruker Catalyst AFM (Bruker AXS,
Santa Barbara, CA) that was mounted on an inverted optical microscope (Observer Z1,
Carl Zeiss Microscopy, Jena, Germany). This allowed simultaneous optical visualization
and force measurement. The cantilevers with triangular-shaped tips (SNL-C, Bruker,
f0:40-75 kHz, k: 0.32 N/m) have been used previously (Preta et al. 2016; Ruiz-Rincon et
al. 2017). Sensitivity of the cantilevers were calibrated in dry conditions on a clean glass
surface to measure the spring constant using the thermal method (Stark et al. 2001). The
sensitivity was calibrated again in liquid. Nucleoli were randomly selected to measure
stiffness. The Young’s modulus was calculated using the Derjaguin–Mueller–Toporov
model.

=

4
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Where E* is the reduced Young’s modulus, Ftip is the force on the tip, Fadh is the
adhesion force, R is the tip end radius and d is the tip-sample separation.
Young’s moduli in control and H2O2-treated or SELENOH knockout nucleoli
were averaged per experiment. Each set of experiments was repeated at least three times,
averaged and illustrated as histograms with SEM.
2.3.16 Immunofluorescence
Immunofluorescence was performed on control and SELENOH knockout HeLa
cells that were grown on circular coverslips in 12-well plates to 50% to 70% confluence.
Cells were incubated in the presence or absence of 4 μM NU7441, an inhibitor of DNAdependent protein kinase (Leahy et al. 2004), and/or 2 μM KU60019, an inhibitor of
ATM (Harding et al. 2015), for 1 hour prior to addition of H2O2 (1 mM) for 15 min.
Followed by extensive washing (three times on ice in drug-free medium) and incubation
at 37 C for up to 4 h in medium with or without inhibitors. Actinomycin D (0.2 μg/mL,
Sigma) was added to the culture media for 2 h. All drugs were added to cells such that the
final concentration of DMSO was 0.1% and the results were compared with controls that
were incubated with 0.1% DMSO alone. Coverslips were washed in PBS and fixed in 4%
formaldehyde at 25°C for 30 min. Following 0.3% Triton X-100 permeabilization, cells
were blocked for 1 h at 25°C in PBS+0.02% Tween 20 (PBST)/5% BSA. Primary
antibodies were diluted in blocking buffer, added to coverslips, and incubated overnight
at 4 °C. After washing with PBST, goat anti-rabbit or donkey anti-mouse secondary
antibodies that were conjugated to AlexaFluor 488 or 568 (Invitrogen) were diluted
(1:500) in PBST and incubated at 25°C for 1 h. After washing with PBST, coverslips
were mounted in ProLong Gold Antifade Mountant that contained DAPI (Thermo
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Scientific Scientific). Images were captured with a Zeiss LSM 510 confocal microscope
and a 63 × oil objective (Carl Zeiss Microscopy, Jena, Germany). Images were prepared
for publication using ImageJ software (NIH), and all panels of a given image were only
adjusted for brightness and contrast. Primary antibodies and dilutions were: 53BP1,
1:1000 (NB100-904, Novus) and UBF, 1:100 (F-9, Santa Cruz).
2.3.17 Statistical analysis
Data were represented as mean ± SEM. The one-way analysis of variance
(ANOVA) was conducted to determine the effect of the SELENOH gene knockout on cell
performance. Differences among groups were determined by least square difference tests.
All analysis was conducted using SAS (SAS 9.4, Cary, NC) at a significance level of P <
0.05.
2.4 Results
2.4.1 Generation of SELENOH knockout cells
In order to understand the functional roles of SELENOH, SELENOH knockout
cells were generated with the use of the CRISPR/Cas9 system. SELENOH contained
three exons. Because there was another ATG codon at the end of exon 1 (93 bp), a
shortened SELENOH may be expressed by beginning from this alternative start codon
if CRISPR is edited upstream of the exon 1. A truncated SELENOH that contained exons
1 and 2 was likely to be expressed if the CRISPR targeted SELENOH exon 3. Thus, two
sgRNAs that targeted exon 2 of SELENOH gene, SELENOH-CR1 and SELENOH-CR2,
were cloned into a Cas9-expressing lentiviral transfer vector lentiCRISPRv2. While
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SELENOH-CR1 covered the selenocysteine codon (TGA) and targeted the beginning of
the exon 2, SELENOH-CR2 matched the middle part of exon 2 (Figure 2.2).
HEK 293T and HeLa cells were transduced with the lentiCRISPRv2 construct,
followed by maintenance in complete DMEM medium that contained puromycin to select
for resistant cells. Seven days later, cells were grown in the puromycin-deprived medium
for an additional 16 d. Results from RT-qPCR analysis demonstrated that SELENOH
mRNA levels were reduced (P < 0.05) in HEK 293T and HeLa cells that were transduced
with SELENOH-CR1 and SELENOH-CR2 lentiCRISPRv2 knockout constructs (Figure
2.3). SELENOH mRNA levels were reduced by 83% in SELENOH-CR2-transfected
HeLa cells and more than 90% reduction in SELENOH-CR1-transfected HeLa cells and
SELENOH-CR1- or SELENOH-CR2- transfected HEK 293Tcells. SELENOH mRNA
levels did not differ (P > 0.05) in knockout cells that were generated by SELENOH-CR1
and SELENOH-CR2 knockout constructs.
2.4.2 Cell growth
Cell numbers were reduced (P < 0.05) in HEK 293T (44 and 55%) and HeLa (43
and 48%) cells 6 days after transfection with SELENOH-CR1 and SELENOH-CR2
lentiCRISPRv2 knockout constructs (P > 0.05) (Figure 2.4). The impact of SELENOH
knockout on proliferation showed no difference between these two constructs.
Furthermore, SELENOH knockout HeLa cells showed morphological changes and were
multinucleated (Figure 2.9).
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2.4.3 Single-cell derived clones and sequence analysis
Because the multinucleated phenotypes were observed in HeLa but not in noncancerous 293T cells, SELENOH loci were sequenced in single-cell-derived clones of
HeLa cells with SELENOH-CR1 lentiCRISPRv2 constructs. As expected, 90% of cells
contained mutations at the proximity of Cas9 excision site. Among the 31 cell lines that
were generated by clonal expansion, 3 were wild-type, and 28 were deletion mutations.
(Figure 2.5). Except the homozygous B6 clone, all other clones had heterozygous
mutations in the two alleles. These mutations were predicted to result in frameshifted,
prematurely terminated, and deleted SELENOH. Interestingly, one allele of clone A11
(A11-a) was wild-type. Although 16 of them were mixed clones based on sequencing
results, the remaining 12 SELENOH mutant cell lines (1 monoallelic and 11 biallelic
mutations) were originated from single clones (Figures 2.5 and 2.6). Results from RNA
sequencing demonstrated that cDNA sequences were present in all of these mutations in
SELENOH, which suggests that both SELENOH gene alleles were expressed.
To study the effects of SELENOH knockout at the mRNA level, cDNA was
prepared from the total RNA of NTC and knockout HeLa cells B6, D3, D4 and D9 and
PCR amplified using primers that were specific for the coding region of SELENOH. The
resulting fragments were cloned into a plasmid. The mRNA sequences obtained from the
NTC HeLa cells were identical to the SELENOH reference sequence and contained 122
amino acids. The mRNA sequences of the homozygous clone B6 and one allele of clone
D3 (D3-a) contained the deletion of 36 bp and 42 bp within exon 2 and resulted in 12 and
14 amino acid deletions, respectively (Figures 2.7 and 2.8).
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For the other allele of clone D3, its gDNA sequence showed deletions of 144 bp
in exon 2, 162 bp for intron 2, 101 bp for exon 3 and 75 bp of gDNA. Its mRNA
sequences altered the splicing at the right exon-intron borders, which resulted in the
deletion of whole exons 2 and 3 and an insertion of 30 bp of gDNA. The deduced amino
acid sequences of D3-b showed a frame-shift mutation and an early stop contained 50 aa
residues from the N-terminus (Figures 2.7 and 2.8).
The mRNA sequences of the two alleles of clone D4 corresponded to their gDNA
sequences, which contained the deletion of 1 bp and 31 bp within exon 2 and resulted in a
frame-shift and an early stop that was contained 66 (D4-a) and 56 (D4-b) residues from
the N-terminus (Figures 2.7 and 2.8).
The mRNA sequences of D9-b altered the correct splicing site. Its gDNA
sequence showed a deletion of 31 bp from intron 1 and 38 bp from exon2, but its mRNA
sequence indicated that the whole exon 2 (146 bp) spliced off and resulted in a frameshift and an early stop that contained only 48 residues (Figures 2.7 and 2.8).
For D9-a, its gDNA sequence showed that 76 bp were deleted from intron 1, 146
bp from exon 2 and 53 bp from intron 2, and its mRNA sequence showed that exon 2 and
3 were spliced off and contained insertions of 15 bp in intron 1 and 28 bp in intron 3
sequences, which resulted in a frame-shift and an early stop that contained 54 aa residues.
Clone B6 and D3-a produced a truncated protein product in which 12 and 14
residues were missing. D3-b and clones D4 and D9-b showed aberrant splicing with a
frame-shift in generating an early stop with a severely truncated protein. These changes
may produce dysfunctional proteins, and that can be expected to be knockouts.
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2.4.4 SELENOH knockout hampers mitosis and the number and size of nucleoli in
HeLa cells
Microscopic examination SELENOH knockout HeLa cells revealed a
multinucleated phenotype (Figure 2.9 A). Although 2.9% of the non-targeting control
HeLa cells were multinucleated, such a phenotype accounted for 7.4-21.1% in 7 clones
(B6, D3, D4, D9, A10, A11, and C4) of SELENOH knockout cells (Figure 2.9 B).
Among these SELENOH knockout cell lines, the multinucleated phenotype was the most
prominent (21.1%) in cells derived from the D3 clone. The multinucleated cells that were
derived from the D3 clone were up to 22 times larger than control cells and contained up
to 18 nuclei (Figure 2.9 C). DAPI staining revealed that multinucleated SELENOH
knockout cells had an abnormal organization of nuclei (Figure 2.9 C), which may
impede normal mitosis and result in incomplete karyokinesis without cytokinesis. Four
SELENOH knockout cell lines (B6, D3, D4 and D9) had the highest percentage of
multinucleated phenotype and were therefore selected for further analyses.
In these four SELENOH knockout cells, the number of nuclei per multinucleated
cell ranged from 2 to 18 (Figure 2.9 C). In contrast, the 3% multinuclear NTC cells had
two nuclei per cell and most likely represented mitotic cells. Not only was the number of
nuclei changed when the SELENOH genes were deleted, but also the total nuclear area
was changed as shown in Figure 2.10 C. When compared to the nuclear area of NTC
cells (204.7 µm2), B6, D3, D4 and D9 nuclei had greater nuclear areas (P < 0.05), which
were 272.0, 398.3, 286.5 and 259.3 µm2, respectively.
Like many other functional domains in the nucleus, the nucleolus is not bound by
a membrane. The nucleolus is also one of the most highly dynamic organelles in terms of
number, size and shape, which vary significantly by cell type, cell-cycle stage and culture
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conditions (Thiry & Lafontaine 2005). SELENOH is known to be the only nucleolar
selenoprotein that is known by sequence analysis (Zhang et al. 2016) and expressed in
the nucleoli when tagged to green fluorescence protein (Novoselov et al. 2007). We
hypothesized that depletion of SELENOH disrupts nucleolar stability. To address this
hypothesis, control and SELENOH knockout HeLa cells were simultaneously stained
with DAPI and SYTO RNASelect as indicators of the nuclei and nucleoli, and observed
under confocal microscopy (Figure 2.10 A).
Ribosomal gene clusters form the nucleolus organizer regions (NORs) are located
on chromosomes 13, 14, 15, 21, and 22 in humans and express 5.8S, 18S, and 28S
ribosomal RNAs. Human cells could, in theory, have 10 nucleoli. However, this is rarely
observed likely due to the natural clustering of NORs and the failure of all NORs to
become activated (Booth et al. 2014). In our HeLa NTC cells, most cells contained more
than one nucleolus, and the average number of nucleoli per nucleus is 2.13. In the
multinucleated SELENOH knockout HeLa cells, there were two phenotypes. First, as
shown in Figure 2.10 A-a, the nuclei contained a clear nuclear envelope that is
predominantly carried by a single large nucleolus. Second, as shown in Figure 2.10 A-b,
the nuclear envelope was broken down, the nucleoli were disassembled, and their
components were dispersed. It is noteworthy that, in higher eukaryotes, nucleoli undergo
a cycle of disassembly and reassembly during mitosis (Thiry & Lafontaine 2005). When
cells exit mitosis, nucleolar components reassemble around the individual NORs, which
can later coalesce to form either one or multiple functional nucleoli (Leung et al. 2004).
The knockout of SELENOH resulted in a decreased (P < 0.05) number of countable
nucleoli (Figure 2.10 A-a) per nucleus from 2.13 in NTC cells to 1.63, 1.54, 1.71 and
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1.81 in B6, D3, D4, and D9 cells, respectively (Figure 2.10 B). Results of the calculation
of nucleolar areas showed that nucleoli were aggregated in SELENOH knockout
multinucleated cells. When compared to the nucleolar area in NTC HeLa cells (32.6
µm2), that in D3, D4 and D9 SELENOH knockout cells had greater (P < 0.05; 57.4, 46.5,
and 40.2 µm2, respectively) nucleolar areas. However, the nucleolar area (38.4 µm2) in
B6 SELENOH knockout cells was not different (P > 0.05) from the NTC cells (Figure
2.10 C). When compared to NTC cells, the relative nucleolar area divided by nuclear area
was decreased (P < 0.05) by 10% in B6 knockout cells and 12.2% in D3 knockout cells;
however, a nucleolar area divided by nuclear area remained unchanged in the D9 and D4
knockout cells (Figure 2.10 E).
2.4.5 Cell cycle analyses in SELENOH knockout cells
The phenotype of incomplete mitosis with multinucleated cells (Figure 2.9) is
consistent with reduced proliferation in SELENOH knockout HeLa cells (Figure 2.4),
which was likely the cause of cell death. Results of flow cytometric analyses indicated
that the percent sub-G1 and S phase cell populations did not differ (P > 0.05) between the
control and the four SELENOH knockout HeLa cells (Figure 2.11). The percent G1
phase cells were decreased (P < 0.05) in the four SELENOH knockout cells when
compared to NTC. In contrast, G2/M content was increased in the D3 knockout clone (up
to 22%, P < 0.05), but not in B6, D4 or D9 knockout clones. The polyploid DNA content
was increased (B6, 1.8-fold; D3, 2.3-fold; D4, 1.2-fold; D9, 2.1-fold; P < 0.05) in the
four SELENOH knockout when compared to the control HeLa cells.
These results suggest that apoptosis is not associated with reduced proliferation in
SELENOH knockout HeLa cells; rather, these cells did not complete mitosis, resulting in
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the multinucleated feature and reduced G1 cell population. Analyses of DAPI and SYTO
stained cells displayed near complete cell segregation, since there was re-appearance of
nucleoli and chromatin formation, with the exception of two daughter cells. These results
suggest a role of SELENOH in cytokinesis.
2.4.6 Activities of two antioxidant enzymes and protein oxidation in SELENOH
knockout HeLa cells
Since SELENOH is known as a thioredoxin-like protein and carries glutathione
peroxidase activity (Novoselov et al. 2007), the impact of SELENOH knockout on GPX
and TXNRD activities was determined. The thioredoxin system is one of the critical
cellular redox regulators, and TXNRD is the only group of enzymes known to catalyze
the reduction of thioredoxin (Kim et al. 2004). The D3 clone of SELENOH knockout
cells has higher (P < 0.05) GPX (2.9-fold) and TXNRD (50%) activities than the NTC
control HeLa cells (Figure 2.12 A-B). GPX and TXNRD activities were not different (P
> 0.05) between the NTC control and the B6, D4, or D9 SELENOH knockout HeLa cells.
Protein carbonyl contents were comparable between the NTC control and the four
SELENOH knockout HeLa cells (Figure 2.12 C).
2.4.7 Knockout of SELENOH induces cellular senescence in the multinucleated cells
Senescent cells often exhibit an increase in the number of multinucleated cells
(Matsumura 1980). The observation of multinucleation in SELENOH knockout cells
prompted the investigation of cellular senescence in these cells. Senescence-associated βgalactosidase (SA-β-gal) is a lysosomal enzyme that is overexpressed and accumulates in
senescent cells (Yuan et al. 2008). As shown in Figure 2.13, SA-β-gal expression was
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11- to 31-fold higher (P < 0.05) in the four SELENOH knockout cells than the NTC cells.
In particular, almost all adherent multinucleated cells were SA-β-gal positive.
2.4.8 SELENOH knockout cells display sustained DNA damage response before and
after treated with H2O2
Senescence in human cells is associated with oxidative stress and DNA damage
(Chen et al. 1995; Campisi & d'Adda di Fagagna 2007), both of which can result in ATM
pathway activation (Wu et al. 2014). ɣ-H2AX and ATM phosphorylation on Ser-1981
(pATM) are well-defined markers for DNA breaks and ATM pathway activation
(Bakkenist & Kastan 2003; Lobrich et al. 2010). Thus, ɣ-H2AX and pATM levels were
evaluated in SELENOH knockout and NTC Hela cells.
Results of Western analyses showed that SELENOH knockout rendered HeLa
cells induced (P < 0.05) ATM activation in the absence of H2O2, 60 min after treatment
with 0.01-0.1 mM H2O2 (Figure 2.14 A), and 0-240 min after treatment with 1 mM H2O2
(Figure 2.14 B). The level of pATM displayed a time-dependent increase (0-4 h) in NTC
cells in response to H2O2 treatment (1 mM), ATM activation by 1 mM H2O2 treatment
reached a plateau at 15 min (Figure 2.14 B). Level of pATM did not differ (P > 0.05)
between NTC and SELENOH knockout HeLa cells when they were treated with H2O2 at
0.5 or 1.0 mM for 60 min. Level of ɣ-H2AX was comparably induced by H2O2 treatment
at 0.5 or 1 mM for 60 min in NTC and SELENOH knockout HeLa cells (Figure 2.14 A).
However, there was a time-dependent (0-240 min) increase (P < 0.05) in ɣ-H2AX level
after treatment with 1 Mm H2O2, the extent of which was greater in SELENOH knockout
than in NTC HeLa cells (Figure 2.14 B). UBF and C23 protein levels did not differ (P >
0.05) after H2O2 treatment or between NTC and SELENOH knockout HeLa cells.
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2.4.9 Nucleolar stiffness measurement
The nucleolus, a nuclear body with flexible structures, is best known for its
functions in ribosome biogenesis. It has been demonstrated that SELENOH locates to the
nucleoli. The impact of SELENOH knockout on stiffness and structure of the nucleoli
was determined by immunofluorescence and AFM. Nucleoli were isolated from the
control and SELENOH knockout HeLa cells with or without H2O2 treatment. Force was
applied to the center of a nucleolus with the use of a pyramidal-shaped tip of the
cantilever. Considering the heterogeneous nature of nucleoli, Young’s moduli of
biological samples are not absolute values and expressed as related to control
(Radmacher 1997; Yokokawa et al. 2008). Analyses of nucleolar stiffness by AFM
showed that Young’s moduli were greater (D3, 1.8-fold, and D9, 1.6-fold, P < 0.05; B6,
1.4-fold and D4, 1.4-fold, P > 0.05) in SELENOH knockout cells than control HeLa cells
(Figure 2.15). However, Young’s moduli did not differ (P > 0.05) between H2O2
treatment in SELENOH knockout or control HeLa cells. These results are consistent with
our unpublished results of RNA-Seq, which indicates that SELENOH knockout in HeLa
cells downregulated ribosome biogenesis. The downregulated ribosome biogenesis may
lead to the accumulation of unprocessed rRNA within the nucleolus that increased
stiffness. The nucleolar stiffness of the RPS6 and RPL11 knockdown proteins was
increased in a previous study (Louvet et al. 2014). The morphological changes in
SELENOH knockout HeLa cells may also contribute to the stiffness in the nucleoli.
2.4.10 SELENOH knockout induces nucleolar reorganization
Tumor suppressor p53-binding protein 1 (53BP1) is recruited to DNA break sites
and is a marker for this form of DNA damage (Panier & Boulton 2014; Zimmermann &
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de Lange 2014). The number of 53BP1 foci were greater (P < 0.05) in the D3 SELENOH
knockout cells when compared to control HeLa cells for both non-treated and H2O2
treated groups (Figure 2.16 A-B). H2O2 treatment of D3 SELENOH knockout and control
HeLa cells induced 53BP1 focus formation in a comparable manner. As a positive control
for nucleolar caps, actinomycin D treatment induced 53BP1 focus formation in D3
SELENOH knockout and control HeLa cells at a similar level (P > 0.05). Pretreatment
with the ATM kinase inhibitor KU60019, but not the DNA-PK kinase inhibitor NU7441,
attenuated the H2O2-induced 53BP1 focus formation in a SELENOH-independent
manner (Figure 2.16 A and C). The positive control, actinomycin D treatment induced
UBF cap formation in D3 SELENOH knockout and control HeLa cells in a similar
manner (P > 0.05). Altogether, results suggest that SELENOH prevents the formation of
H2O2-induced DNA breaks and nucleolar cap formation in an ATM-dependent manner.
2.5 Discussion
Despite substantial advances characterizing the molecular and biochemical
features of SELENOH (Ben Jilani et al. 2007; Novoselov et al. 2007; Stoytcheva et al.
2010; Wu et al. 2014), functional and physiological understanding of this selenoprotein is
lacking. Genetic knockouts of individual selenoprotein genes have been applied in cells
to elucidate their physiological functions. Through CRISPR/Cas9-mediated genomeediting, SELENOH was knocked out in HeLa and 293T cells. Results from the RT-qPCR
analysis showed that SELENOH mRNA levels were reduced (P < 0.05), but still
detectable. This is because Cas9 cleaves the gene of interest and creates a doublestranded break (DSB) in the DNA, which can be repaired by non-homologous end joining
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(NHEJ) (Sander & Joung 2014). As NHEJ is an error-prone DNA repair process,
insertions and deletions (indels) are often introduced into the gene, resulting in
frameshifts and mutations that potentially lead to loss-of-function. Thus, it is necessary to
determine indels in both alleles and to clarify whether the mutant is monoallelic or
biallelic. Consequently, monoallelic mutations or, in rare occasions, wildtype cells may
exist in the knockout population. To achieve a functional gene knockout, it is necessary
to perform single colony screening to confirm and select clones with biallelic mutations.
Analysis at the genomic level revealed expected insertion/deletion (indel) alterations in
exon 2 which was targeted within the SELENOH gene where the functional motif CXXU
locates. Based on the sequenced genome, protein sequences indicated various forms of
mutants including frame-shift by aberrant splicing and truncated SELENOH by early
termination of translation. Although CRISPR/Cas9 edited SELENOH mRNAs are
expressed, they are expected to be translated as dysfunctional SELENOH that are subject
to degradation.
SELENOH knockout cell lines expressed a reduced growth rate (P < 0.05) when
compared with control cells. This is likely attributed to the following: 1) cell death is
more frequent in SELENOH knockout cells; 2) the cell cycle is blocked. Cell cycle
analysis indicated that the control and SELENOH knockout cells had a similar, low
proportion of apoptotic cells. These results suggest that increased apoptosis is not
associated with reduced proliferation in SELENOH knockout cells. Instead, the decreased
G1 cell population and increased G2/M population and polyploid DNA content in
SELENOH knockout cells indicated that this selenoprotein has a critical role in the G2/M
phase of the cell cycle.
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Knockout of SELENOH leads to a mitotic defect and accumulation of
multinucleated cells. Analyses of DAPI- and SYTO-stained cells display near complete
mitosis as evidenced by the re-appearance of nucleoli and chromatin formation without
separation of two daughter cells. These results suggest that SELENOH has a role in
cytokinesis. Multinucleation can arise from defects in DNA replication, cell proliferation,
or mitosis and from the aberrant expression of proteins that regulate these critical cellular
events (Faye et al. 2013).
Accumulation of multinucleated cells has been reported in HeLa cells that are
deficient in the NF45 nuclear factor (Guan et al. 2008; Shamanna et al. 2011). Timelapse microscopy results indicate that the multinucleated NF45-deficient cells originated
from the incomplete cytokinesis of daughter cells, followed by the fusion of several
binucleated cells (Shamanna et al. 2011). Thus, NF45 may be required for the proper
progression of mitosis. In addition, the NF90-NF45 complex regulates the repair of DNA
double-strand breaks by non-homologous end-joining that requires DNA-activated
protein kinase (DNA-PK). These results suggest that the multinucleated phenotype may
be attributed to defective DNA double-strand break repair (Shamanna et al. 2011).
Furthermore, the multinucleated phenotype has been observed in X-ray-irradiated HeLa
cells (Huang et al. 2008; Shang et al. 2010) and cells that are deficient in DNA-PKcs or
Ku80 with defective DNA double-strand break repair (Difilippantonio et al. 2000;
Shamanna et al. 2011).
Experiments on the down-regulation of ILF2 in 1q21-amplified MM cells indicate
the expression of multinucleated phenotypes and abnormal nuclear morphologies,
including nucleoplasmic bridges, nuclear buds, and micronuclei (Marchesini et al. 2017).
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These observations suggest genomic instability in replicating cells. Other proteins that are
essential to mitosis and whose aberrant expression has been linked to multinucleation
include survivin (Colnaghi et al. 2006), aurora (Yan et al. 2005), and ORC6 (Prasanth et
al. 2002). Altogether, observations from the current study on the multinucleated
phenotype are consistent with these reports and suggest a defective DNA damage
response, cell cycle progression, and cytokinesis in SELENOH-deficient cells.
Because SELENOH is reported to carry GPX activity and a TXN-like domain
(Novoselov et al. 2007), it was determined whether or not the knockout of SELENOH
impacted GPX and TXNRD activities. SELENOH knockout cells increased (P < 0.05)
GPX activity. GPX enzymatically decomposes oxidized peroxides, H2O2, and lipid
peroxides and can be stimulated by oxidative stress (Lee et al. 1990; Avissar et al. 1996).
Altogether, these enzymes can neutralize oxidants at the expense of GSH, which is
replenished through GSSG reduction. An increase in GPX activity and expression usually
occurs as an adaptive response to increased oxidative stress (Velsor et al. 2001).
Upregulation of this enzyme system in SELENOH knockout cells suggests increased
oxidative stress in the cell.
SELENOH contains an AT-hook motif and is a member of the high-mobility
group (HMG) family of DNA-binding proteins (Panee et al. 2007). Proteins in this family
bind DNA minor grooves and specific DNA sequences, thus regulating various aspects of
DNA metabolism such as DNA repair, replication, and transcription (Grosschedl et al.
1994). SELENOH shRNA knockdown in MRC-5 human primary cells induced genomic
instability and cellular senescence (Wu et al. 2014). In the current study, the knockout of
SELENOH in HeLa cells resulted in increased (P < 0.05) pATM on Ser-1981 and γ58

H2AX as evidenced by Western analyses and increased 53BP1 foci by
immunofluorescence. However, H2O2-induced 53BP1 focus formation was exacerbated
and inhibited by DNA-PK and ATM inhibitors. These results suggest that ATM has an
essential role in the DNA damage response. These results are consistent with previous
research that, under ambient O2 level (20%), SELENOH shRNA MRC-5 cells display
ATM pathway activation and intrinsic DNA breaks (Wu et al. 2014). These data suggest
that SELENOH has a critical and general role in the maintenance of genomic stability
against chronic oxidative stress.
Knockdown of SELENOH by shRNA results in replicative senescence in MRC-5
human normal diploid fibroblasts, but not in cancerous HeLa cells (Wu et al. 2014).
Knockout of SELENOH by CRISPR/Cas9 genomic editing renders human cancerous
HeLa cells susceptible to premature cellular senescence. Based on SELENOH mRNA
levels, the 20% residual SELENOH mRNA may confer the shRNA HeLa cells from
senescence responses (Wu et al. 2014). However, the depletion of this selenoprotein by
CRISPR/Cas9 induces senescence in the same cancer cells. This suggests a need of
minimal SELENOH (~ 20%) in the protection of HeLa cancerous cells from senescence
induction. Thus, SELENOH is essential for the protection against cellular senescence in
both non-cancerous and cancerous cells, although the former is more susceptible than the
latter to the defect. Increased cellular senescence in SELENOH knockout HeLa cells may
be attributed to the accumulation of unrepaired DNA damage and chronic oxidative
stress.
Furthermore, the knockout of SELENOH results in the accumulation of
multinucleated cells, and almost all adherent multinucleated cells were SA-β-gal positive.
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Consistent with these results, a recent study indicated that NF45 knockdown HeLa cells
exhibit a striking senescence-like morphology and multinucleated phenotype, which
suggests a cell fusion event or a defect in cytokinesis in these cells (Faye et al. 2013).
More recently, it was reported that knockdown of coilin expression accelerates
premature cellular senescence and increased chemo-sensitivity in HeLa cells (Song et al.
2017). Coilin is a hallmark protein of the Cajal body, which is a distinct nuclear area that
is physically and functionally associated with the nucleolus (Shaw et al. 2014). This
suggests that modulation of SELENOH expression could be considered as a potential
anti-tumor strategy. It is of future interest to determine whether chemosensitivity can be
increased through accelerated senescence in SELENOH knockout cells.
Cellular and biochemical studies and computational analyses of nuclear
localization sequences indicated that SELENOH is a genuine nucleolar protein in the
nucleus (Zhang et al. 2016). Furthermore, the structural integrity of the nucleoli may be
necessary for cellular stress responses (Leung et al. 2004). Therefore, it was determined
whether or not the knockout of SELENOH impacted nucleolar size, number, mechanical
property and nucleolar component localization.
The nucleolus is a dynamic nuclear structure that assembles and disassembles
during each round of mitotic cell division (Leung & Lamond 2003). Nucleoli in Xenopus
laevisoocytes are liquid-like droplets of RNA and protein (Brangwynne et al. 2011). The
number, size, and shape of nucleoli vary significantly by cell type, cell-cycle stage and
cell culture conditions (Thiry & Lafontaine 2005).
In the current study, nucleoli were stained with SYTO RNASelect, and cell nuclei
were counterstained with DAPI. SYTO RNASelect stain is a cell-permeable proprietary
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cyanine dye with preferential staining of the nucleoli (Pickard & Bierbach 2013; Luciani
et al. 2017). SELENOH knockout HeLa cells had larger nuclei than control cells and
possessed one single large nucleolus. The phenotype of single large nucleoli could be
attributed to the cell fusion event or a defect in cytokinesis. By a study of the nucleolar
cycle in embryonic ovarian and kidney cells (Anastassova-Kristeva 1977), it was found
that during prophase, large G2 nucleoli disassemble into small nucleoli nucleate and
grow on the NORs upon completion of cytokinesis. These nucleoli increase in size as
components continue assembling; moreover, the size appears to increase while their
number decreases, probably due to fusion events. Ki-67 is one of the earliest proteins to
bind the perichromosomal layer in mitosis. Loss of Ki-67 in HeLa cells renders small
nuclei that are accompanied by a large nucleolus (Booth et al. 2014). This may occur
because chromosomes that lack a perichromosomal layer might associate with one
another more closely than normal, thus promoting NOR fusion during reactivation.
Another possibility is that, upon Ki-67 depletion, the efficiency of NOR reactivation is
reduced during mitotic exit. Nonetheless, the mechanism of the single nucleolus
phenotype in SELENOH knockout cells is presently unknown. It is of future interest to
determine whether or not SELENOH impacts mitotic chromosome periphery.
To investigate the mechanical properties of nucleoli in SELENOH knockout cells,
AFM was used to assess nucleolar stiffness. The observation of increased stiffness in the
nucleoli of SELENOH knockout cells suggests that SELENOH maintains the flexibility
of the nucleolus structure. Furthermore, our unpublished results of RNA sequencing
show that SELENOH knockout downregulates ribosome biogenesis in HeLa cells, which
may accumulate unprocessed rRNA and consequently lead to increased stiffness in the
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nucleolus. Consistent with this notion, it is known that knockdown of the ribosomal
proteins RPS6 and RPL11 caused increased nucleolar stiffness in HeLa cells (Louvet et
al. 2014). It is also possible that the morphological changes may have an influence on the
measurement of stiffness in the nucleoli.
Cellular response to DSBs is required to cope with ongoing defects in normal
DNA metabolism such as transcription in the nucleus. Similarly, nucleolar DSBs can
result in a transient block in rRNA synthesis by silencing RNA polymerase I (Pol I)
transcription (Kruhlak et al. 2007). The transcriptional silencing caused by DSBs can
segregate the nucleolar structure into nucleolar caps (Shav-Tal et al. 2005). Nucleolar
caps are known to be induced in response to various forms of DNA damage such as
DSBs (Larsen & Stucki 2016). The formation of the caps has some advantages. First, by
presenting the damaged rDNA at the nucleolar periphery, it is accessible to recruiting
repair factors from the nucleoplasm. Second, the caps concentrate high levels of
homologous sequences in close proximity to each other, which could promote repair by
homologous recombination (van Sluis & McStay 2017).
As described above, SELENOH knockout cells display increased cellular stress
and DSBs, which may lead to reorganization of the nucleolar architecture. To determine
how SELENOH knockout influences the nucleolar structure, the localization of nucleolar
proteins upstream binding factor (UBF) before and after H2O2 treatment was examined.
SELENOH knockout cells induced (P < 0.05) the redistribution of UBF into caps that
were localized in close proximity to DAPI-sparse nucleoli. Interestingly, the nucleolar
cap formation in H2O2-treated HeLa cells was dependent on ATM signaling, which is
consistent with the known functional interactions between SELENOH and ATM in
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senescence (Wu et al. 2014). Such a role of SELENOH in the maintenance of genomic
stability in the nucleoli may be critical for embryogenesis and protection against
carcinogenesis in mice (Chapter 3) and zebrafish (Cox et al. 2016).
The nucleolus has been proposed to serve as a stress sensor (Boulon et al. 2010).
There are a few types of stress that can lead to marked changes in the nucleolar
organization. Nucleolar DSBs can be generated by ionizing radiation or UV microbeams
that induce ATM-dependent silencing of Pol I transcription (Kruhlak et al. 2007). Cells
irradiated with 10 Gy of -irradiation also display UBF segregation and re-distribution to
nucleolar caps, a hallmark of transcriptionally inactive cells (Shav-Tal et al. 2005;
Kruhlak et al. 2007). Induction of DSBs within the rDNA repeats by I-PpoI expression
confirms the inhibition of nucleolar transcription upon the induction of DSBs in rDNA
and segregation of nucleolar structure into nucleolar caps (Harding et al. 2015; van Sluis
& McStay 2015). Thus, it is of future interest to elucidate the mechanism by which
SELENOH regulates rDNA transcription and nucleolar cap formation.
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2.6 Figures and Tables

Figure 2.1

Nucleotide and derived amino acid sequences of SELENOH gene and six
primers for PCR amplification.

The sequences of three introns are presented in lowercase letters. The translational stop
codon is marked with an asterisk. The first nt (A) of translation start codon (ATG) is
assigned as position 1 in the nt sequence, and the nt positions upstream of position 1 are
presented with minus numbers. The sequence and direction of each primer are denoted by
a long arrow. Primers HSH_CDS_F and HSH_CDS_R are used for mutation analysis.
Primers HSH_CR1_F and HSH_CR1_R, HSH_CR2_F and HSH_CR2_R are used for
RT-qPCR assays targeted to SELENOH_CR1 and SELENOH_CR2 mutated cells,
respectively.
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Figure 2.2

Schematic illustration of the SELENOH sgRNA/Cas9-expressing
lentiCRISPRv2 constructs for SELENOH knockout.

SELENOH-CR1 and SELENOH-CR2 are the sgRNA-targeting sites and located in the
sense and anti-sense strands of the exon 2, respectively. tracrRNA and sgRNA-targeting
sites are shown in red and green, respectively. psi+, Psi packaging signal; RRE, Revresponsive element; cPPT, central polypurine tract; U6, Pol III promoter; EFS, human
elongation factor 1α promoter; SpCase9, Streptococcus pyogenes Cas9 gene; P2A,
porcine teschovirus-1 self-cleaving peptide fragment; Puro, puromycin-resistant gene;
WPRE, woodchuck hepatitis virus posttranscriptional regulatory element.
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Figure 2.3

SELENOH mRNA levels in 293T and HeLa cells transfected with nontargeting control (NTC), SELENOH-CR1 (CR1) and SELENOH-CR2
(CR2) lentiCRISPRv2 constructs.

Values are mean ± SEM (n = 3). *, P < 0.05, compared to NTC. Data were normalized to
Actb (β-actin) mRNA and calculated related to the NTC cells.
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Figure 2.4

Effects of SELENOH gene knockout on proliferation in 293T and HeLa
cells transfected with non-targeting control (NTC), SELENOH-CR1 (CR1)
and SELENOH-CR2 (CR2) lentiCRISPRv2 constructs.

Cell numbers were determined by a hemocytometer daily. Values are mean ± SEM (n =
3). *, P < 0.05, compared to NTC.
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16 not single
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Figure 2.5

Details of the 31 SELENOH knockout HeLa cells derived from clonal
expansion.

Figure 2.6

Genomic DNA Sequences of SELENOH loci from clones of HeLa cells
infected with SELENOH-CR1 lentiCRISPRv2 constructs.

Top row indicates the sequence of unmodified allele SELENOH-CR1. sgRNA sequence
was shown in green and PAM sequences in red. Deletion events are shown by an
equivalent number of dash marks and insertions is highlighted in blue. Vertical lines
indicate predicted cleavage site. The black box indicates selenocysteine codon.
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Figure 2.7

Consequences of the CRISPR/Cas9-mediated SELENOH knockout in HeLa
cells (B6, D3, D4 and D9) at mRNA level.

Top row indicates the sequence of the unmodified allele. Deletion events are shown by an
equivalent number of dash marks and insertions is highlighted in blue.

Figure 2.8

Deduced amino acid sequences of SELENOH based on mRNA sequence
analysis of the open reading frame of SELENOH genes in SELENOH
knockout HeLa cells.

All the deletion mutations in SELENOH resulted in deduced changes of SELENOH as
frameshift (highlighted in red), premature termination (an asterisk), or deletion (dash
line).
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Figure 2.9

Morphological changes in SELENOH knockout HeLa cell lines.

(A) Bright-field and fluorescent images of control and SELENOH knockout D3 cell line.
(B) Quantitation of multinucleated cells in NTC control and 7 SELENOH knockout
clones. Multinucleated cells were counted in three fields of at least 100 cells each.
Percent multinucleated cells were plotted for each cell line (n = 3). *, P < 0.05, compared
to NTC. (C) Giant cells are containing interconnected nuclei. DAPI images of DNAstained multinucleated cells with incomplete karyokinesis.
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Figure 2.10

Changes in the number and size of nucleoli in SELENOH knockout cells.

(A) Representative fields of SELENOH knockout (D3) and non-targeting control (NTC)
HeLa cells and images enlarged nuclei and nucleoli. DAPI and SYTO are markers of
nuclei and nucleoli, respectively. (B) Quantification of the nucleolar number in 100
control and SELENOH knockout cells. Values are mean ± SEM. *, P < 0.05, compared to
NTC. (C) Quantification of the nuclear area and the nucleolar area in 100 control and
SELENOH knockout cells. Values are mean ± SEM. *, P < 0.05, compared to NTC cells.
(D) A 2D scatter plot showing combined nucleolar area (per nucleus) on the Y axis, vs
nuclear area on the X-axis, for control (yellow) and SELENOH knockout D3 (blue) cells.
Each translucent dot represents one nucleus. The red dot represents the mean value of
control cells, and the green dot represents the mean value of D3 cells. (E) Quantification
of the relative area of nucleoli per nuclei. Values are mean ± SEM. *, P < 0.05, compared
to NTC cells.
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Figure 2.11

Cell cycle analyses in control (NTC) and SELENOH knockout (B6, D3, D4
and D9) cells.

Cells were stained with propidium iodide and analyzed with the use of a BD
FACSCalibur flow cytometer. The percent sub-G1, G1, S, G2/M and polyploid cells were
assessed by using FlowJo V10 software. Values are mean ± SEM, n = 3. *, P < 0.05,
compared to NTC.
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Figure 2.12

Glutathione peroxidase (A) and thioredoxin reductase (B) activities and
protein carbonyl level (C) in control and SELENOH knockout HeLa cells.

Specific enzymatic activities were expressed as related to sample protein amount. Values
are mean ± SEM (n = 3). *, P < 0.05, compared to NTC. GPX, glutathione peroxidase;
TXNRD, thioredoxin reductase
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Figure 2.13

SELENOH knockout HeLa cells display exacerbated senescence induction.

(A) Cells were stained for the detection of senescence-associated β-galactosidase (SA-βgal), and images were taken with a 10× objective lens. (B) Quantification of the SA-β-gal
positive cells. Values are mean ± SEM (n = 3). *, P < 0.05, compared to NTC. NTC, nontreating control; B6, D3, D4, and D9 are SELENOH knockout HeLa cells.
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Figure 2.14

Knockout of SELENOH rendered HeLa cells enhanced ataxia telangiectasia
kinase (ATM) activation in the absence and presence of H2O2 treatment.

Western analyses of the indicated proteins in non-targeting control (NTC) and the D3
clone of SELENOH knockout cells treated with H2O2 (0-1 mM) for 60 min (A) or 1 mM
for 0-240 min (B). pATM and H2AX were normalized to ATM and actin, respectively,
and expressed as relative to the no H2O2 group. pATM, phosphorylated ATM on Ser1981; H2AX, phosphorylated H2AX on Ser-139; C23, nucleolin; UBF, upstream
binding factor.
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Figure 2.15

The stiffness of nucleoli in control and SELENOH knockout HeLa cells
with or without H2O2 treatment.

Stiffness was directly assessed using Young’s moduli with the use of atomic force
microscope, as expressed as related to untreated HeLa cells. Values are presented as
mean ± SEM of three independent experiments. *, P < 0.05, compared to control (NTC)
HeLa cells. B6, D3, D4 and D9 are SELENOH knockout cells as detailed in Fig. 2.9.
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Figure 2.16

SELENOH knockout resulted in the large-scale reorganization of nucleolar
architecture with the movement of nucleolar proteins into nucleolar cap
regions in response to cellular stress and DSBs.

(A) Immunofluorescence staining of 53BP1 (green) and UBF (red). ActD treatment
serves as a control for cap formation in the absence of H2O2 treatment. (B) Quantification
of 53BP1 foci per nucleus for the experiment described in (A). (C) Quantification of the
percentage of nuclei with UBF nucleolar caps for the experiment described in (A). Values
are presented as mean ± SEM of three independent experiments. *, P < 0.05, compared to
NTC. #, P < 0.05, compared to non-treated cells. +, P < 0.05, compared to H2O2+DMSO
treated cells.
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SELENOPROTEIN H IS PARTIALLY ESSENTIAL FOR EMBRYOGENESIS AND
PROTECTS AGAINST COLON CARCINOGENESIS
3.1 Abstract
Selenium is an essential mineral, in which there is a significant negative
correlation between selenium intake and incidence of different cancers in humans. The
biological properties of selenium are mediated mainly by selenoproteins at nutritional
levels and selenium metabolites. Selenoprotein H (SELENOH) carries redox domains
and suppresses oxidative stress to maintain genome stability in vitro. However, its
function in vivo remains largely unknown. To determine the physiological role of
SELENOH function in vivo, Selenoh knockout mice were generated by targeted deletion
through homologous recombination. Selenoh+/− mice were fertile and phenotypically
indistinguishable from wild-type littermates. Results from matings of Selenoh+/− mice
showed a significantly reduced fraction of Selenoh−/− offspring on the basis of Mendelian
segregation. Because some Selenoh−/− were born, this suggested that Selenoh is a partially
essential gene in mice. Live-born Selenoh−/− mice were viable and born without apparent
phenotypes. Selenoh−/− mice at 2-month of age showed increased GPX activity in the
lung but not in the brain and liver. Furthermore, loss of Selenoh resulted in the
aggravated formation of aberrant crypt foci in the colon of Selenoh+/− mice that were
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injected with azoxymethane (AOM). Results indicated that SELENOH has important
roles during embryogenesis and in colorectal carcinogenesis.
3.2 Introduction
Selenium is known to mitigate certain forms of age-related degeneration such as
cancer, cardiovascular diseases, and neurologic disorders (Rayman 2012). The biological
properties of selenium are mediated mainly by selenoproteins at nutritional levels and
selenium metabolites at supranutritional levels (Qi et al. 2010; Labunskyy et al. 2014).
Since most selenoproteins have antioxidant activity (Moghadaszadeh & Beggs 2006), it
can be assumed that higher selenium intake would lead to the higher expression of
selenoproteins within the nutritional level, hence protecting DNA against oxidative
damage.
SELENOH carries redox domains and suppresses oxidative stress to maintain
genome stability in vitro. However, its physiological functions remain largely unknown.
It was recently reported that SELENOH is essential for organ development in zebrafish
(Cox et al. 2016). In particular, larvae of SELENOH-deficient zebrafish exhibit an
increased susceptibility to oxidative stress and DNA damage, and this selenoprotein
interacts with p53 in adulthood to palliate gastrointestinal tumor development. These
findings strongly suggest that SELENOH has a critical role in the maintenance of redox
homeostasis and genome stability. Compared to cell models and the non-mammalian fish,
mouse models are particularly useful to determine selenoprotein functions in humans. To
date, no Selenoh knockout model has been reported in mice. To fill this key knowledge
gap, Selenoh+/− mice were generated through homologous recombination and bred from
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Selenoh−/− and Selenoh +/+ to conduct experiments that address the physiological
functions of this nucleolar selenoprotein.
With the use of knockout mice, selenoproteins that are known to be essential for
embryogenesis include GPX4 (Yant et al. 2003), TXNRD1 (Jakupoglu et al. 2005) and
TXNRD2 (Conrad et al. 2004). Interestingly, Dio3 knockout mice exhibit impaired
growth, low fertility and partial perinatal lethality (Hernandez et al. 2006). In contrast,
mice that were deficient in SELENOP (Hill et al. 2003; Schomburg et al. 2003), GPX1
(Cheng et al. 1997), GPX2 (Esworthy et al. 2000), GPX3 (Jin et al. 2011), MSRB1
(Fomenko et al. 2009), SELENOF (SEP15) (Kasaikina et al. 2011), DIO1 (Schneider et
al. 2006b), DIO2 (Schneider et al. 2001), SELENOK (Verma et al. 2011), SELENOM
(Pitts et al. 2013) were viable. In the current study, the generation and characterization of
Selenoh knockout mice are described. Mating of Selenoh heterozygous knockout mice
suggests SELENOH is partially essential during embryogenesis in mice. Selenoh−/− mice
exhibit increased GPX activity in the lung, but not in the brain and liver. Loss of
SELENOH develops increased aberrant crypt foci in the colon of Selenoh+/− mice that
were injected with azoxymethane, suggesting that SELENOH may function as a caretaker
type of tumor suppressor.
3.3 Materials and Methods
3.3.1 Generation of Selenoh knockout mice
Selenoh+/− mice were made through targeted disruption (Cyagen Biosciences,
Santa Clara, CA). To engineer the targeting vector, homology arms were generated by
PCR using BAC clone RP23-134L7 or RP23-259I24 from the C57BL/6J library as
template. Mouse genomic fragments were amplified from the BAC clone with high
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fidelity Taq DNA polymerase and were assembled into a targeting vector together with
recombination sites and selection markers.
Male and female Selenoh +/− mice were mated, and genotypes (Selenoh +/+,
Selenoh +/− or Selenoh−/−) of their offspring were tested by PCR at 3-4 weeks of age.
Mouse DNA was isolated by standard procedures after proteinase K digestion of tail
snips. DNA was resuspended in Tris-EDTA buffer (10 mM Tris-Cl, 1 mM EDTA, pH
7.6). The PCR protocol consisted of 38 cycles that included 30 seconds at 94 °C, 35
seconds at 60 °C, and 35 seconds at 72 °C, with a final extension of 5 min. The primers
used were as follows: MoSeHF, 5′-CCAAACACCTCTAGACCTCAACTTCC-3′;
MoSeHwtR, 5′-CCTTCAAGCCCAACTACGCTATCA-3′; MoSeHkoR, 5′TCCCAGCAATCTAGAGGCAGAGG-3′. The PCR products were 458 bp for the
Selenoh+/+ allele with the use of the MoSeHF and MoSeHwtR primers and 341 bp for the
Selenoh−/− allele with the use of the MoSeHF and MoSeHkoR primers.
3.3.2 Animal husbandry
Experiments were approved by the IACUC (approval numbers are 13-133, 14054, 16-575, 17-033) of Mississippi State University and conducted in accordance with
the NIH guidelines for the care and use of laboratory animals. Mice were given free
access to diets and distilled water and housed in ventilated cages (up to 4 mice/cage) in
an animal room (22-23°C, 12:12 h light-dark cycle). Weanling mice were fed an AIN93G purified diet that contained 0.15 ppm Se as sodium selenate until they were
sacrificed. Mice were weighed weekly.
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3.3.3 Mating of Selenoh+/− mice
Selenoh+/− mice were mated, and their pups were monitored as previously
described (Hernandez et al. 2006) to determine the impact of knocking out SELENOH on
reproduction and viability of the pups. This was done to determine whether or not
Selenoh is an essential gene.
3.3.4 Sample collection and preparation of tissue homogenates
Mice were anesthetized with carbon dioxide and sacrificed by exsanguination via
heart puncture using a heparinized syringe. Tissues were rinsed with PBS solution (pH
7.4) to clean out blood cells and clots, snap-frozen in liquid nitrogen, and stored at -80 °C
until analyses. Tissues were powdered and homogenized under liquid nitrogen and
sonicated in cold buffer. Homogenates were resuspended in cold buffer and centrifuged
at 10,000  g for 20 min at 4 C. Protein concentrations were estimated using Pierce BCA
protein assay (Thermo Scientific Scientific) with bovine serum albumin as a standard.
3.3.5 Glutathione peroxidase (GPX) activity
Brains, lungs and livers were homogenized by sonication in 200 µL ice-cold
buffer (50 mM Tris-HCl, pH 7.5, 5 mM EDTA, and 1 mM DTT) and centrifuged (20,000
 g at 4 °C for 10 min). The supernatant was collected and kept on ice for immediate
analysis of total GPX activity as described in 2.3.10.
3.3.6 Thioredoxin reductase (TXNRD) activity
Brains and lungs were homogenized by sonication in 200 µL ice-cold buffer (50
mM potassium phosphate, pH 7.4, 1 mM EDTA) and centrifuged (20,000  g at 4 °C for
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10 min). The supernatant was collected and kept on ice for immediate analysis of total
TXNRD activity as described in 2.3.11.
3.3.7 Protein oxidation
Livers were homogenized by sonication in a buffer (MES, 50 mM; EDTA, 1mM;
pH 6.7), followed by centrifugation at 10,000  g for 15 min at 4 °C. The supernatant was
incubated at room temperature for 15 min with streptomycin sulfate (1%). After
centrifugation at 6,000  g for 10 min at 4 °C, the protein carbonyl content in the
supernatant was measured as described in 2.3.12.
3.3.8 Animals and carcinogen treatment
Since a recent study showed that SELENOH functioned as a tumor suppressor in
zebrafish with carcinogen-induced tumorigenesis (Cox et al. 2016), the impact of Selenoh
haploinsufficiency in old mice (15-22 months of age) with AOM-induced intestinal
carcinogenesis was evaluated in the next phase of our research.
Mice received either weekly intraperitoneally (i.p.) injections of azoxymethane
(AOM, an intestinal carcinogen) (Sigma) (Selenoh+/+, n = 8; Selenoh+/−, n = 6) at a
concentration of 8 mg/kg body weight or saline carrier solution (Selenoh+/+, n = 3;
Selenoh+/−, n = 3) for 4 weeks, followed by 15 mg/kg for one week. Body weight was
recorded weekly throughout the experiments. Mice were anesthetized with carbon
dioxide 13 weeks after the first AOM injection. Colons were excised from the caecum at
the ileo-caecal valve and rinsed with 0.25 M sucrose/10 mM tris buffer, pH 7.4, to
remove colon contents. The cecum, anus, and rectum were removed. Colons were
trisected starting at the distal end into three equal lengthwise segments that were
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operationally defined as descending, transverse, and ascending regions. Segments of
colon tissue were prepared by laying the serosal surface down onto 75 × 25 mm 3aminopropyltriethoxysilane-treated microscope slides (Statlab Medical Products,
McKinney, TX, Cat. No. 418), fixed flat in buffered formalin for 16 h, and stained with
methylene blue (0.2% (v/v) in PBS) for 30 min. By viewing the stained colons under a
light microscope at a magnification of 40 , the number of ACF per colon was
determined as described previously (Chung et al. 2003; Padidar et al. 2012).
3.3.9 Statistical analysis
The one-way analysis of variance (ANOVA) was conducted to determine the
effect of the genotype on enzymatic activities of mouse organs. Differences among
groups were determined by least square difference tests. All analysis was conducted
using SAS (SAS 9.4, Cary, NC) at a significance level of P < 0.05. Survival analysis was
conducted using GraphPad Prism version 7.0 (GraphPad Software, La Jolla, CA).
3.4 Results
3.4.1 Generation of mice deficient in Selenoh
Mouse Selenoh gene is located in the reverse strand of chromosome 2 and
contains 4 exons. Selenoh knockout mice were generated with the use of the strategy of
homologous recombination as detailed in Figure 3.1 A. The targeting vector contains
homology arms, a neomycin cassette that is flanked by two loxP sites, and a DTA
cassette. After completion of homologous recombination, the Selenoh gene was replaced
with a neomycin cassette, followed by Cre-mediated excision to generate the constitutive
knockout allele. C57BL/6 blastocysts were then injected with Selenoh+/− embryonic stem
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cells and implanted into pseudopregnant mice. A male chimera was identified among the
offspring. This male was mated with two C57BL/6 female mice, and the heterozygote
progeny (Selenoh+/−) from these mating events were used to establish the Selenoh
knockout mouse colony. Selenoh+/+, Selenoh+/−, and Selenoh−/− alleles in these mice were
verified by PCR genotyping as detailed in Figure 3.1 B.
3.4.2 Selenoh is a partially essential gene during embryogenesis
Selenoh+/− mice were fertile and phenotypically indistinguishable from wild-type
littermates. When Selenoh+/− mice were intercrossed, a significantly reduced fraction of
Selenoh−/− offspring was born on the basis of Mendelian segregation. Instead of the
expected 25% by the principle of segregation, only 10.7% (8 of 75; P < 0.005, χ2) were
Selenoh−/− (Table 3.1). This suggests that more than half of the homozygous knockout
mice were lost during pregnancy. Thus, Selenoh is a partially essential gene in mice.
However, the delivered Selenoh−/− mice appeared healthy as evidenced by normal weight
gains (Figure 3.2) and lack of apparent phenotype for up to 14 months of age at the time
of death. Interestingly, an approximately equal number of Selenoh+/+ and Selenoh+/− mice
were born instead of the 1:2 ratio based on Mendelian segregation. This suggests that
haploinsufficiency of Selenoh promote embryonic lethality. Similarly, Selenoh+/− mice
appeared healthy up to 22 months of age at the time of sacrifice. According to Mendelian
segregation, there were 48% and 76% less neonatal Selenoh+/− and Selenoh−/− mice,
respectively, this is strongly indicating an essential role of Selenoh in embryogenesis in a
manner depending on gene dosage.
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3.4.3 Activity of antioxidant enzymes and carbonyl contents in tissues of Selenoh+/+
and Selenoh−/− mice
Body weight gains did not differ Selenoh+/+ and Selenoh−/− mice during the 8week experiment (Figure 3.2). Weanling Selenoh+/+ and Selenoh−/− mice were sacrificed
at week 8. Because SELENOH carries GPX activity and a TXN-like domain (Novoselov
et al. 2007), the impact of Selenoh knockout was evaluated for its GPX and TXNRD
activities. Pulmonary GPX activity in Selenoh−/− mice was 28.5% greater (P < 0.05) than
that in Selenoh+/+ mice (Figure 3.3 A). Knockout of Selenoh in mice did not affect GPX
activity in the brain or liver (P > 0.05) (Figure 3.3 A), TXNRD activity in the brain or
lung (Figure 3.3 B), and carbonyl content in the liver (Figure 3.3 C).
3.4.4 AOM-induced aberrant crypt foci (ACF) in Selenoh+/+ and Selenoh+/− mice
It was recently reported that SELENOH deficiency (heterozygous mutant) disrupts
redox homeostasis, provokes an inflammatory response, activates p53 in development,
and accelerates the onset of tumors in zebrafish (Cox et al. 2016). To determine such a
role of SELENOH in mammals, Selenoh+/+ and Selenoh+/− mice were intraperitoneally
injected with AOM or saline weekly for 5 weeks. While there was no significant weight
gain or loss in mice injected with saline during the experimental period, injection with
AOM resulted in reduced (P < 0.05) body weights by 37% in Selenoh+/+ and 34% in
Selenoh+/− mice over the course of 7 weeks (Figure 3.4 B and C).
In accordance with our approved animal protocol by IACUC, the following mice
were killed following AOM injection as determined by inertia, ruffled fur, and >11%
weight loss in a week: 1) one Selenoh+/+ mouse at week 4, 2) four Selenoh+/+ and three
Selenoh+/− mice at week 5, and 3) Selenoh+/− mouse each at 7 and 11 weeks (Figure 3.4
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A). One Selenoh+/+ and one Selenoh+/− mice injected with saline were sacrificed 7 weeks
after the injection as determined by aging phenotypes that are different from those
injected with AOM.
AOM-induced ACF in the colon of experimental mice were counted (Table 3.2).
The Selenoh +/− mouse had more (P < 0.05) lesions (19.5 ± 4.5 ACF/mouse) than Selenoh
+/+

mice (4.3 ± 0.9 ACF/mouse). The ACF that were identified were all located in the

lower part of the colon with no ACF observed in the proximal part of the colon. None of
the saline injected mice developed ACF. Although the difference is substantial, further
studies are needed to confirm this preliminary observation.
3.5 Discussion
The gene knockout approach has been a valuable tool in functional genomics for
understanding various physiological aspects of a given gene product. Mice act as a good
analog for many biological processes in humans because ~99% of their genes are
overlapped (Capecchi 1994). Another advantage in using mice as the mammalian model
is that they are relatively small, cost-effective, prolific, and easy to handle. Although
there are more sophisticated strategies to manipulate gene expression such as conditional
or tissue-specific knockout, targeted deletion is typically the initial knockout approach
that is used in research.
To date, genetic manipulation of Selenoh has not been reported in mice. We
employed targeted disruption to achieve whole body Selenoh knockout in mice. In this
study, the physiological function of the SELENOH was investigated in mice. Selenoh+/−
mice were fertile and phenotypically indistinguishable from wild-type littermates. When
Selenoh+/− mice were intercrossed, a reduced fraction of Selenoh−/− offspring was born by
Mendelian segregation. These results suggested that Selenoh is a partially essential gene
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in mice. This is similar to DIO3, as Dio3−/− mice are partially lethal by a reduced
proportion of Dio3−/− pups (17.5%) as compared to the 25% rate predicted by Mendelian
law when Dio3+/− mice were intercrossed (Hernandez et al. 2006).
Similar to the essential roles of Selenoh and Dio3 in embryogenesis, a
mammalian-specific microRNA (miRNA) cluster mir-290-295 is critical early in life
(Medeiros et al. 2011). Like SELENOH, the mir-290-295 primary transcript is
specifically expressed in early embryos. When heterozygous mir-290-295 knockout mice
were intercrossed, only 7% (32 of 452, P<0.001, χ2) of 4-wk-old postnatal progeny were
mir-290–295−/−, suggesting that about three-quarters of the homozygous knockout
animals were lost. Interestingly, at E18.5, just before birth, the percentage of mir-290–
295−/−embryos was also 7% (3 out of 46, P<0.01, χ2). This suggests that mir-290-295 is
essential only during embryogenesis because ll live-born mir-290–295−/−mice will likely
be survived. Indeed, analysis of embryos at mid-late gestation suggest that mir-290–
295−/− embryos are lost over a period between E11.5 and E18.5. It is of future interest to
determine the mechanism by which embryonic lethality is expressed in Selenoh−/− mice.
Complete embryonic lethality exhibits in mice with a whole-body knockout in
genes coded for certain selenoproteins or their biosynthesis factors. First, Gpx4−/−
embryos die by E7.5 (Yant et al. 2003). Second, Txnrd1−/− embryos die between E9.5 and
E10.5 (Jakupoglu et al. 2005). Third, Txnrd2−/− embryos die around E13.0 due to defects
in hematopoiesis and heart development (Conrad et al. 2004). Early studies indicated that
Trsp−/− embryos die shortly after implantation and are resorbed by 6.5 days post coitum
(Bosl et al. 1997). Trsp codes for selenocysteine (Sec)-specific tRNA gene are necessary
for the expression of all selenoproteins. As such, Trsp−/− mice are null in all 24
selenoproteins. Similarly, selenocysteine insertion sequence (SECIS)-binding protein 2
(Secisbp2) plays a central role in UGA/Sec recoding and is necessary for the expression
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of all selenoproteins. As expected, intercrosses of Secisbp2+/− mice yield no live
Secisbp2−/− offspring, and dissection of Secisbp2−/− embryos demonstrate developmental
retardation by embryonic day 8 (E8). While Secisbp2−/− embryos are developmentally
arrested at the Theiler stage 7 (TS7), control embryos reach the appropriate TS12 (Seeher
et al. 2014). Similarly, selenocysteine tRNA 1 associated protein (Trnau1ap) has been
characterized as a tRNA[Ser]Sec-binding protein, and homozygous mice with constitutive
deletion of exons 7 and 8 of Trnau1ap die during embryogenesis (Mahdi et al. 2015).
Altogether, selenium is essential for life and it's physiological essentially is mediated by
selenoproteins. To date, at least 5 selenoproteins are necessary for embryogenesis, with
Gpx4−/−, Txnrd1−/− and Txnrd2−/− being essential and Dio3−/− and Selenoh−/− being
partially essential.
Selenoh−/− mice are viable and born without obvious phenotype. Selenoh−/− mice
have the similar body weight gains within 8 weeks of age compare with Selenoh+/+ mice.
Interestingly, Selenoh−/− mice show increased GPX activity in the lung but not in the
brain and liver. GPX is a H2O2-eliminating enzyme and can be upregulated by oxidative
stress (Lee et al. 1990; Avissar et al. 1996). The upregulation of GPX activity is
indicative of the presence of an increased oxidant burden in the lung of Selenoh−/− mice.
Knockout of Selenop in mice results in decreased GPX activities in the brain,
testis and kidney, but increased activity in the liver. Hepatic accumulation of selenium in
combination with drastic declines of selenium content in the plasma, brain, testis, and
kidney in Selenop−/− mice implies that other tissues depend on the delivery of selenium
by SELENOP from the liver.
A strong body of epidemiologic, clinical, and experimental studies collectively
show that dietary selenium plays an important role in cancer prevention (Clark et al.
1996; Peters et al. 2006). Evidence suggests that selenium has cancer preventive
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properties that are largely mediated through selenoproteins (Tsuji et al. 2012). It is
reasonable to expect selenoproteins to have antitumorigenic roles because some cancers
appear to be subjected to redox regulation. In this regard, glutathione peroxidases 1-4 and
6 and thioredoxin reductases 1-3 are potential regulators of carcinogenesis (Saad &
Diamond 2016). In particular, Gpx1−/−Gpx2−/− mice exhibit bacteria-induced
inflammation (colitis) that spontaneously drives intestinal tumor formation (Esworthy et
al. 2001). GPX2 appears to play a complicated role in colon carcinogenesis (BrigeliusFlohe & Kipp 2012) because it inhibits inflammation-driven tumorigenesis (Krehl et al.
2012) yet promotes the growth of xenografted tumors at different stages of
carcinogenesis (Banning et al. 2008). Loss of Gpx2 leads to dedifferentiation of cells to a
progenitor-like state (Emmink et al. 2014). Conversely, overexpression of Gpx2 leads to
cell differentiation, with increased proliferation and tumor-forming potential. In addition,
knockout of Txnrd1 in the liver of mice results in increased susceptibility to chemically
induced hepato-carcinogenesis (Carlson et al. 2012).
It has recently been reported that SELENOH deficiency (heterozygous mutant)
disrupts redox homeostasis, provokes an inflammatory response, activates p53 in
development, and accelerates gastrointestinal tumor development in adulthood zebrafish
(Cox et al. 2016). To determine such a role of SELENOH in mammals, Selenoh+/+ and
Selenoh+/− mice were intraperitoneally injected with AOM and the induced aberrant
crypts foci were counted. Aberrant crypt foci are putative pre-neoplastic colon lesions
and are considered ideal biomarkers of colorectal carcinogenesis, as the number of preneoplastic lesions is statistically associated with the number of tumors that ultimately
develop (Pretlow et al. 1992; Takayama et al. 1998). The Selenoh +/− mice has more
lesions (19.5 ± 4.5 ACF/mouse) than Selenoh +/+ mice (4.3 ± 0.9 ACF/mouse).
Interesting, all the ACFs in Selenoh +/− mice are located in the lower part of the colon,
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with no ACF being observed in the proximal colon. These results suggest that Selenoh
contributes to the suppression of colon carcinogenesis.
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3.6 Figures and Tables

Figure 3.1

Targeted disruption of Selenoh in C57BL/6 mice.

(A) Genomic structure of the wildtype mouse Selenoh locus, the targeting vector, and the
targeted locus are shown. Black boxes represent Selenoh exons. PGK-Neo, neomycin
resistance cassette; Not I, a linearization site. (B) Representative results from PCR
genotyping of wild-type (+/+), heterozygous knockout (+/−), and homozygous knockout
(−/−) Selenoh mice.
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Figure 3.2

The growth of Selenoh+/+ and Selenoh−/− mice fed an AIN-93G diet for 8
weeks since weaning. Numbers were mean ± SEM of measurements (n = 410).
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Figure 3.3

Selenoh+/+ mice

Selenoh-/- mice

Glutathione peroxidase (A) and thioredoxin reductase (B) activities and
protein carbonyl level (C) in tissues of Selenoh+/+ and Selenoh−/− mice.

Specific enzymatic activities were expressed as related to sample protein amount. Values
are mean ± SEM (n = 3). *, P < 0.05, compared to Selenoh+/+ mice. GPX, glutathione
peroxidase; TXNRD, thioredoxin reductase
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Figure 3.4

Effect of AOM injection on survival (A) and body weight in Selenoh +/+ (B)
and Selenoh +/− (C) mice. Values are mean ± SEM (n = 1-8).
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Table 3.1

Table 3.2

Summary of Selenoh heterozygous intercrosses
Number of newborns (%)

Mutant

+/+

+/−

−/−

Total

Selenoh+/−

33 (44.0)

34 (45.3)

8 (10.7)

75

Body weight and development of ACF

Group
Treatment group
n
Mean ACF/mouse
+/+
Selenoh
Saline
2
0
Selenoh +/+
AOM
3
4.3 ± 0.9 b
+/−
Selenoh
Saline
2
0
Selenoh +/−
AOM
2
19.5 ± 4.5 a
Values are expressed as mean ± SEM; lowercase letters within each column denote
measurements significantly different from each other (P < 0.05); saline-injected mice did
not develop ACF.
Abbreviations: AOM, azoxymethane; ACF, aberrant crypt foci.
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CONCLUSIONS
The overarching aim of this dissertation was to study functional and physiological
roles of SELENOH through gene knockout in cells and mice. We created SELENOH
knockout cell lines using the CRISPR/Cas9 system. Although a quality antibody is not
available to detect gene expression at the protein level in SELENOH, results from RTqPCR analyses demonstrated that SELENOH mRNA levels were dramatically reduced.
As expected, CRISPR/cas9 system was effective at genome engineering of SELENOH
knockout in cells. Once the site-specific DSBs were created at predicted deletion
junctions at SELENOH exon 2, the repair of DSBs was triggered by the non-homologous
end-joining pathway. This induced small insertion/deletions that resulted in frameshifts
and the potential loss of function mutations. A high frequency of genomic deletions was
observed. To achieve a functional gene knockout, single colony screening was performed
to select clones with biallelic mutations. By the deduced protein sequences, these biallelic
mutations were translated as dysfunctional SELENOH in various forms including
frameshift mutation by aberrant splicing and truncated SELENOH by early termination
of translation. In this study, because of the small indels at the SELENOH exon 2, most of
the mutations still contain SELENOH exon 1. For a more precise genome editing such as
deletion of the whole coding sequence of SELENOH, it is of future interest to employ an
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alternative DNA repair pathway of homology-directed repair (HDR) by providing a
homologous donor template.
To date, genetic manipulation of Selenoh has not been reported in mice. We
employed the targeted disruption method to produce the whole body Selenoh knockout
mice and investigated the physiological function of the SELENOH in mice. Selenoh+/−
mice were fertile and phenotypically indistinguishable from wild-type littermates. When
Selenoh+/− mice were intercrossed, a reduced fraction of Selenoh−/− offsprings were born
on the basis of Mendelian segregation. These results suggest that Selenoh is necessary for
embryogenesis and partially essential in mice. It is of future interest to test the Selenoh−/−
males and females’ fertility by setting up different mating combinations between
Selenoh+/− and Selenoh−/− mice.
SELENOH knockout cell lines reduced cell proliferation and accumulation of
giant multinucleated cells. Cell cycle analysis demonstrated that apoptosis is not
associated with the observed slow cell growth. Instead, the decreased G1 cell population
and increased G2/M population and polyploid DNA content in SELENOH knockout cells
indicate that this selenoprotein has a critical role in the G2/M phase of the cell cycle.
Confocal microscopy analysis of DAPI- and SYTO-stained SELENOH knockout cells
displayed near complete mitosis as evidenced by the re-appearance of nucleoli and
chromatin formation without separation of two daughter cells. Altogether, these results
suggest that SELENOH has a role in cytokinesis. Cytokinesis is the final step of cell
division and appears to proceed as a linked set of subreactions: cleavage plane
specification, furrow assembly, furrow ingression and cell separation (Glotzer 1997).
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Further studies are warranted on the regulation of SELENOH in the core pathways and
components essential for each stage of cytokinesis.
Knockout of SELENOH in HeLa cells may induce oxidative stress DNA damage
as evidenced by increased GPX activity, the persistence of pATM on Ser-1981 and γH2AX expression and 53BP1 focus formation. These results suggest that SELENOH has
both critical and general role in maintaining genomic stability against chronic oxidative
stress. The knockout of SELENOH by CRISPR/Cas9 genomic editing renders human
cancerous HeLa cells susceptible to premature cellular senescence. These results suggest
that modulation of SELENOH expression could be evaluated further for its potential antitumor properties. It is of future interest to determine whether chemosensitivity could be
increased through accelerated senescence in SELENOH knockout cells.
SELENOH is a nucleolar protein. The nucleolus is a dynamic nuclear structure.
Knockout of SELENOH changes the size, number, mechanical property and nucleolar
component localization in the nucleolus. We found that in SELENOH knockout HeLa
cells have larger nuclei than control, which possess a single large nucleolus. Nonetheless,
the mechanism of the single nucleolus phenotype in SELENOH knockout cells is
presently unknown. It would be interesting to research whether or not SELENOH
impacts mitotic chromosome periphery and/or cytokinesis. AFM was used to assess
nucleolar stiffness. The observation of increased stiffness in the nucleoli of SELENOH
knockout cells suggests that SELENOH maintains the flexibility of the nucleolus
structure. Furthermore, our unpublished results of transcriptome analysis by RNAseq
show that SELENOH knockout downregulates ribosome biogenesis in HeLa cells, which
may lead to the accumulation of unprocessed rRNA and consequently leads to increased
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stiffness in the nucleolus. Interestingly, knockout of SELENOH renders large-scale reorganization of nucleolar architecture in HeLa cells with the movement of nucleolar
proteins into nucleolar cap regions in response to oxidative stress. The nucleolar
reorganization is dependent on ATM signaling. SELENOH appears to be both a sensor of
oxidative stress in the nucleolus and has critical roles in redox regulation and genome
maintenance. Thus, it is of future interest to elucidate the mechanism by which
SELENOH regulates rDNA transcription and nucleolar cap formation.
Selenoh−/− mice are viable and born without an obvious phenotype. Selenoh−/−
mice have the similar body weight gains within 8 weeks of age compared with Selenoh+/+
mice. Selenoh−/− mice had increased GPX activity in the lung but not in the brain and
liver. The upregulation of GPX activity is indicative of the presence of an increased
oxidant burden in the lung of Selenoh−/− mice. To determine whether or not SELENOH
plays a role in tumor development in mammals, Selenoh+/+ and Selenoh+/− mice were
intraperitoneally injected with azoxymethane to induce aberrant crypts foci (ACF) at the
early stage of colorectal carcinogenesis. The Selenoh +/− mice had more lesions than
Selenoh +/+ mice. All the ACFs in Selenoh +/− mice are located in the lower part of the
colon, and no ACF is observed in the proximal colon. These results suggest that Selenoh
plays an important role in the suppression of colon carcinogenesis.
SELENOH maintains genome stability in the nucleolus by the regulation of redox
homeostasis and may suppress DNA damage during embryogenesis and carcinogenesis.
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Table A.1

LIST OF ABBREVIATION

Abbreviated

Full Name

53BP1

p53-binding protein 1

ACF

Aberrant crypt foci

AFM

Atomic force microscopy

AOM

Azoxymethane

ATM

Ataxia talengiectasia kinase

Cas9

CRISPR-associated (Cas) 9 system

CRISPR

Clustered regularly interspaced short palindromic repeats

DIO

Dodothyronine deiodinases

DNA-PK

DNA-dependent protein kinase

DNA-PKcs

DNA-dependent protein kinase, catalytic subunit

DSB

Double-stranded break

GFP

Green fluorescent protein

GPX

Glutathione peroxidases

HDR

Homology-directed repair

HMG

High-mobility group

HRP

Horseradish peroxidase

Indel

Insertion and deletion

miRNA

microRNA

MSRB1

Methionine sulfoxide reductase B1, SelR, SepR, SelX

NHEJ

Nonhomologous end-joining

NLS

Nuclear localization signal

NORs

Nucleolus organizer regions

NTC

Non-targeting control

PAM

Protospacer adjacent motif

Pol I

RNA polymerase I

RNA-Seq

RNA sequencing
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SA-β-gal

Senescence-associated β-galactosidase

SBP2

SECIS-binding protein 2

Se

Selenium

Sec

Selenocysteine

SECIS

Selenocysteine insertion sequence

SELENOF

Selenoprotien F, Sep15

SELENOH

Selenoprotein H

SELENOI

Selenoprotein I

SELENOK

Selenoprotein K

SELENOM

Selenoprotein M

SELENON

Selenoprotein N

SELENOP

Selenoprotein P

SELENOT

Selenoprotein T

SELENOS

Selenoprotein S

SELENOV

Selenoprotein V

SELENOW

Selenoprotein W

SEPHS2

Selenophosphate synthetase-2

SEPSECS

Selenocysteine synthase

sgRNA

Single guide RNA

shRNA

Short hairpin RNA

ROS

Reactive oxygen species

TGR

Thioredoxin glutathione reductase

TRSP

Selenocysteinyl tRNA

TXN

Thioredoxin

TXNRD

Thioredoxin reductases

UBF

Upstream binding factor
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